10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

T	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended May 31, 2012
or
£	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ..... to .....

Commission file number: 001-14669

HELEN OF TROY LIMITED

(Exact name of registrant as specified in its charter)

Bermuda	74-2692550
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
Clarenden House Church Street Hamilton, Bermuda
(Address of principal executive offices)
1 Helen of Troy Plaza
El Paso, Texas	79912
(Registrant’s United States Mailing Address)	(Zip Code)

(915) 225-8000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                                      Yes T        No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).           Yes T       No £

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer T	Accelerated filer £
Non-accelerated filer    £ (Do not check if a smaller reporting company)	Smaller reporting company £

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes £      No T

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at July 2, 2012
Common Shares, $0.10 par value, per share	31,736,452 shares

HELEN OF TROY LIMITED AND SUBSIDIARIES

INDEX – FORM 10-Q

			Page
PART I.	FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Consolidated Condensed Balance Sheets (unaudited) as of May 31, 2012 and February 29, 2012	3
		Consolidated Condensed Statements of Income (unaudited) for the Three Months Ended May 31, 2012 and May 31, 2011	4
		Consolidated Condensed Statements of Comprehensive Income (unaudited) for the Three Months Ended May 31, 2012 and May 31, 2011	5
		Consolidated Condensed Statements of Cash Flows (unaudited) for the Three Months Ended May 31, 2012 and May 31, 2011	6
		Notes to Consolidated Condensed Financial Statements (unaudited)	7
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	30
	Item 4.	Controls and Procedures	34
PART II.	OTHER INFORMATION
	Item 1.	Legal Proceedings	35
	Item 1A.	Risk Factors	35
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
	Item 6.	Exhibits	36
	Signatures		37

- 2 -

PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Balance Sheets (unaudited)

(in thousands, except shares and par value)

	May 31,			February 29,
	2012			2012
Assets
Assets, current:
Cash and cash equivalents	$	20,880		$	21,846
Receivables - principally trade, less allowances of $5,153 and $5,541	188,264			195,283
Inventory, net	259,989			246,142
Prepaid expenses and other current assets	8,093			7,645
Deferred tax assets, net	14,724			17,620
Total assets, current	491,950			488,536
Property and equipment, net of accumulated depreciation of $67,498 and $62,550	100,830			100,690
Goodwill	452,285			452,350
Other intangible assets, net of accumulated amortization of $57,800 and $52,268	371,709			377,150
Deferred tax assets, net	627			976
Other assets, net of accumulated amortization of $4,377 and $3,938	15,877			16,021
Total assets	$	1,433,278		$	1,435,723
Liabilities and Stockholders’ Equity
Liabilities, current:
Revolving line of credit	$	158,000		$	171,100
Accounts payable, principally trade	72,911			69,845
Accrued expenses and other current liabilities	113,451			131,632
Income taxes payable	498			352
Deferred tax liabilities, net	887			2,960
Long-term debt, current maturities	3,000			3,000
Total liabilities, current	348,747			378,889
Long-term debt, excluding current maturities	175,000			175,000
Deferred tax liabilities, net	58,261			60,576
Other liabilities, noncurrent	23,800			24,529
Total liabilities	605,808			638,994
Commitments and contingencies
Stockholders’ equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	-			-
Common stock, $0.10 par. Authorized 50,000,000 shares; 31,732,256 and 31,681,067 shares issued and outstanding	3,173			3,168
Additional paid in capital	157,615			151,006
Accumulated other comprehensive loss	(4,464		)	(5,589		)
Retained earnings	671,146			648,144
Total stockholders’ equity	827,470			796,729
Total liabilities and stockholders’ equity	$	1,433,278		$	1,435,723

See accompanying notes to consolidated condensed financial statements.

- 3 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Income (unaudited)

(in thousands, except per share data)

	Three Months Ended May 31,
	2012			2011
Sales revenue, net	$	300,211		$	271,467
Cost of goods sold	179,063			161,554
Gross profit	121,148			109,913
Selling, general and administrative expense	90,000			79,259
Operating income	31,148			30,654
Nonoperating income (expense), net	23			143
Interest expense	(3,312		)	(3,429		)
Income before income taxes	27,859			27,368
Income tax expense:
Current	5,901			1,390
Deferred	(1,514		)	1,373
Net income	$	23,472		$	24,605
Earnings per share:
Basic	$	0.74		$	0.80
Diluted	$	0.74		$	0.78
Weighted average shares of common stock used in computing net earnings per share:
Basic	31,699			30,857
Diluted	31,840			31,660

See accompanying notes to consolidated condensed financial statements.

- 4 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated Condensed Statements of Comprehensive Income (unaudited)

(in thousands)

	Three Months Ended May 31,
	2012									2011
	Before						Net of			Before						Net of
	Tax			Tax			Tax			Tax			Tax			Tax
Net income	$	27,859		$	(4,387	)	$	23,472		$	27,368		$	(2,763	)	$	24,605
Other comprehensive income
Cash flow hedge activity - interest rate swaps
Changes in fair market value	(44		)	15			(29		)	(2,442		)	1,111			(1,331		)
Interest rate settlements reclassified to income	926			(324		)	602			1,526			(695		)	831
Subtotal	882			(309		)	573			(916		)	416			(500		)
Cash flow hedge activity - foreign currency
Changes in fair market value	910			(318		)	592			(487		)	156			(331		)
Ineffectiveness recorded in income	(35		)	12			(23		)	63			(20		)	43
Settlements reclassified to income	(26		)	9			(17		)	144			(46		)	98
Subtotal	849			(297		)	552			(280		)	90			(190		)
Auction rate security activity
Changes in fair market value	-			-			-			42			(22		)	20
Settlements reclassified to income	-			-			-			(120		)	63			(57		)
Subtotal	-			-			-			(78		)	41			(37		)
Total other comprehensive income	1,731			(606		)	1,125			(1,274		)	547			(727		)
Comprehensive income	$	29,590		$	(4,993	)	$	24,597		$	26,094		$	(2,216	)	$	23,878

See accompanying notes to consolidated condensed financial statements.

- 5 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

Consolidated  Condensed Statements of Cash Flows (unaudited)

(in thousands)

	Three Months Ended May 31,
	2012			2011
Cash provided (used) by operating activities:
Net income	$	23,472		$	24,605
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	9,100			7,094
Provision for doubtful receivables	(168		)	227
Share-based compensation	1,602			466
Gain on the sale of property and equipment	(4		)	(24		)
Realized and unrealized loss on investments	-			56
Deferred income taxes and tax credits	(1,804		)	1,373
Changes in operating capital:
Receivables	7,187			(8,634		)
Inventories	(13,742		)	(11,004		)
Prepaid expenses and other current assets	(675		)	(2,862		)
Other assets and liabilities, net	(779		)	(543		)
Accounts payable	3,066			4,224
Accrued expenses and other current liabilities	(18,206		)	(11,002		)
Accrued income taxes	(28		)	447
Net cash provided by operating activities	9,021			4,423
Cash provided (used) by investing activities:
Capital and intangible asset expenditures	(3,368		)	(2,036		)
Proceeds from the sale of property and equipment	7			24
Proceeds from note receivable related to land sale	737			-
Proceeds from sale of investments	-			3,050
Net cash provided (used) by investing activities	(2,624		)	1,038
Cash provided (used) by financing activities:
Proceeds from line of credit	59,950			142,700
Repayment of line of credit	(73,050		)	(160,500		)
Payments of financing costs	(28		)	(24		)
Proceeds from exercise of stock options and employee stock purchases, including tax benefits	5,537			1,182
Directors’ stock repurchased	(37		)	-
Share-based compensation tax benefit	265			25
Net cash used by financing activities	(7,363		)	(16,617		)
Net decrease in cash and cash equivalents	(966		)	(11,156		)
Cash and cash equivalents, beginning balance	21,846			27,193
Cash and cash equivalents, ending balance	$	20,880		$	16,037

See accompanying notes to consolidated condensed financial statements.

- 6 -

HELEN OF TROY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (unaudited)

May 31, 2012

Note 1 - Basis of Presentation and Conventions Used in this Report

The accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of May 31, 2012 and February 29, 2012, and the results of our consolidated operations for the three month periods ended May 31, 2012 and 2011. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 29, 2012, and our other reports on file with the Securities and Exchange Commission (“SEC”).

In this report and the accompanying consolidated condensed financial statements and notes, unless the context suggests otherwise or otherwise indicated, references to “the Company,” “our Company,” “Helen of Troy,” “we,” “us,” or “our” refer to Helen of Troy Limited and its subsidiaries, and amounts are expressed in thousands of U.S. Dollars.  We refer to the Company’s common shares, par value $0.10 per share, as “common stock.” References to “Kaz” refer to the operations of Kaz, Inc. and its subsidiaries.  References to “PUR” refer to the PUR brand of water filtration products that we acquired, along with certain other assets and liabilities, from The Procter & Gamble Company and certain of its affiliates on December 30, 2011. Kaz and PUR comprise a segment within the Company referred to as the Healthcare / Home Environment segment.  References to “OXO” refer to the operations of OXO International and certain of its affiliated subsidiaries that comprise our Housewares segment. Product and service names mentioned in this report are used for identification purposes only and may be protected by trademarks, trade names, services marks, and/or other intellectual property rights of the Company and/or other parties in the United States and/or other jurisdictions. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their owners.  References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to U.S. generally accepted accounting principles. References to “ASC” refer to the codification of U.S. GAAP in the Accounting Standards Codification issued by the FASB.

We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. We have three segments: Personal Care, Housewares and Healthcare / Home Environment. Our Personal Care segment’s products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid, solid- and powder-based personal care and grooming products. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment focuses on health care devices such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances such as air purifiers, portable heaters, fans, and bug zappers. All three segments sell their products primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, and specialty stores. In addition, the Personal Care segment sells extensively through beauty supply retailers and wholesalers, and the Healthcare / Home Environment segment sells certain of its product lines through medical distributors and other products through home improvement stores. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.

Our consolidated condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates.  We have reclassified, combined or separately disclosed certain amounts in the prior period’s consolidated condensed financial statements and accompanying footnotes to conform to the current period’s presentation.

- 7 -

Note 2 – New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that we adopt according to the various timetables the FASB specifies.  Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.

Note 3 – Commitments and Contingencies

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

Notes (7), (9), (10), (11), and (14) provide additional information regarding certain of our significant long-term commitments and certain significant contingencies we have provided for in the accompanying consolidated condensed financial statements.

Our products are under warranty against defects in material and workmanship for periods ranging from two to five years. We estimate our warranty accrual using historical trends and believe that these trends are the most reliable method by which we can estimate our warranty liability.  The following table summarizes the activity in our warranty accrual for the periods covered in the accompanying consolidated condensed statements of income:

ACCRUAL FOR WARRANTY RETURNS

(in thousands)

	Three Months Ended May 31,
	2012			2011
Beginning balance	$	26,665		$	24,021
Additions to the accrual	6,874			7,110
Reductions of the accrual - payments and credits issued	(10,226		)	(6,762		)
Ending balance	$	23,313		$	24,369

Note 4 – Earnings per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period and diluted earnings per share using basic earnings per share plus the effect of dilutive securities.  Our securities that can have dilutive effects consist of outstanding options to purchase common stock and restricted share units.  “In-the-money” options to purchase common stock are dilutive because they have exercise prices that are less than the average market price of our common stock during the period reported.  “Out-of-the-money” options to purchase common stock are antidilutive and are excluded from the computation of earnings per share because the exercise price of the options was greater than the average market price of our common stock during the period reported.  For the periods covered in the accompanying consolidated condensed statements of income, the basic and diluted shares are as follows:

WEIGHTED AVERAGE DILUTED SECURITIES

(in thousands)

	Three Months Ended May 31,
	2012	2011
Weighted average shares outstanding, basic	31,699	30,857
Incremental shares of common stock attributable to share-based payment arrangements	141	803
Weighted average shares outstanding, diluted	31,840	31,660
Dilutive securities, as a result of in-the-money options	423	2,338
Antidilutive securities, as a result of out-of-the-money options	625	407

- 8 -

Note 5 – Segment Information

The following tables contain segment information for the periods covered in the accompanying consolidated condensed statements of income:

THREE MONTHS ENDED MAY 31, 2012 AND 2011

(in thousands)

	Personal				Healthcare / Home
May 31, 2012	Care		Housewares		Environment			Total
Sales revenue, net	$	117,552	$	60,249	$	122,410		$	300,211
Operating income	11,880		11,277		7,991			31,148
Capital and intangible asset expenditures	2,255		191		922			3,368
Depreciation and amortization	3,267		1,298		4,535			9,100
	Personal				Healthcare / Home
May 31, 2011	Care		Housewares		Environment			Total
Sales revenue, net	$	122,718	$	52,946	$	95,803		$	271,467
Operating income (loss)	19,852		10,865		(63		)	30,654
Capital and intangible asset expenditures	897		580		559			2,036
Depreciation and amortization	2,661		1,441		2,992			7,094

We compute operating income for each segment based on net sales revenue, less cost of goods sold, selling, general and administrative expense (“SG&A”), and any impairment charges associated with the segment. SG&A used to compute each segment’s operating income is directly associated with the segment, plus overhead expenses allocable to the segment.  We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facilities square footage.  In fiscal 2013, we began making certain additional cost allocations to the Healthcare / Home Environment segment that were not made in fiscal 2012.  These allocations are costs of corporate and operating functions that are shared by our segments.   We made this change because we now have a complete fiscal year’s operating experience with the Healthcare / Home Environment segment.  In the past year we have integrated certain of the segment’s corporate and operating functions that were redundant. For the three month period ended May 31, 2012, the allocation totaled $4.12 million compared to $1.50 million for the same period last year.  We do not allocate nonoperating income and expense, interest or income taxes to operating segments.

Note 6 – Comprehensive Income (Loss)

The components of accumulated other comprehensive loss, net of tax, are as follows:

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS

(in thousands)

	May 31,			February 29,
	2012			2012
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1)	$	(4,986	)	$	(5,559	)
Unrealized holding gains (losses) on cash flow hedges - foreign currency, net of tax (2)	522			(30		)
Total accumulated other comprehensive loss	$	(4,464	)	$	(5,589	)

(1) Includes net deferred tax benefits of $2.68 and $2.99 million at May 31, 2012 and February 29, 2012, respectively.

(2) Includes net deferred tax benefits (liabilities) of ($0.28) and $0.02 million at May 31, 2012 and February 29, 2012, respectively.

- 9 -

Note 7 – Supplemental Balance Sheet Information

PROPERTY AND EQUIPMENT

(in thousands)

	Estimated
	Useful Lives	May 31,			February 29,
	(Years)	2012			2012
Land	-	$	8,767		$	8,767
Building and improvements	3 - 40	66,953			66,580
Computer, furniture and other equipment	3 - 15	57,475			56,162
Tools, molds and other production equipment	1 - 10	30,165			25,617
Construction in progress	-	4,968			6,114
Property and equipment, gross		168,328			163,240
Less accumulated depreciation		(67,498		)	(62,550		)
Property and equipment, net		$	100,830		$	100,690

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

(in thousands)

	May 31,		February 29,
	2012		2012
Accrued sales returns, discounts and allowances	$	27,885	$	29,481
Accrued warranty returns	23,313		26,665
Accrued compensation, benefits and payroll taxes	16,673		31,754
Accrued advertising	9,865		7,849
Accrued royalties	6,059		6,990
Accrued property, sales and other taxes	6,012		5,745
Accrued legal expenses and professional fees	5,482		5,364
Derivative liabilities	3,464		3,694
Other	14,698		14,090
Total accrued expenses and other current liabilities	$	113,451	$	131,632

OTHER LIABILITIES, NONCURRENT

(in thousands)

	May 31,		February 29,
	2012		2012
Deferred compensation liability	$	4,648	$	4,478
Liability for uncertain tax positions	13,284		13,213
Derivative liabilities	4,207		5,022
Other liabilites	1,661		1,816
Total other liabilities, noncurrent	$	23,800	$	24,529

- 10 -

Note 8 – Goodwill and Intangible Assets

Annual Impairment Testing in the First Quarter of Fiscal 2013 and 2012 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal 2013 and 2012.   As a result, we concluded no impairment charges were required during either period.  For both periods, the estimated fair value of the indefinite-lived trademarks and licenses, reporting unit net assets, and the Company’s estimated enterprise value exceeded their respective carrying values as of the date of the evaluation.

A summary of the carrying amounts and associated accumulated amortization for all intangible assets by operating segment follows:

GOODWILL AND INTANGIBLE ASSETS

(in thousands)

	May 31, 2012										February 29, 2012
	Gross		Cumulative								Gross		Cumulative
	Carrying		Goodwill			Accumulated			Net Book		Carrying		Goodwill			Accumulated			Net Book
Description	Amount		Impairments			Amortization			Value		Amount		Impairments			Amortization			Value
Personal Care:
Goodwill	$	81,842	$	(46,490	)	$	-		$	35,352	$	81,842	$	(46,490	)	$	-		$	35,352
Trademarks - indefinite	75,303		-			-			75,303		75,303		-			-			75,303
Trademarks - finite	150		-			(68		)	82		150		-			(67		)	83
Licenses - indefinite	10,300		-			-			10,300		10,300		-			-			10,300
Licenses - finite	19,564		-			(16,097		)	3,467		19,564		-			(15,967		)	3,597
Other intangibles - finite	49,437		-			(16,505		)	32,932		49,437		-			(15,012		)	34,425
Total Personal Care	236,596		(46,490		)	(32,670		)	157,436		236,596		(46,490		)	(31,046		)	159,060
Housewares:
Goodwill	166,131		-			-			166,131		166,131		-			-			166,131
Trademarks - indefinite	75,200		-			-			75,200		75,200		-			-			75,200
Other intangibles - finite	15,765		-			(9,289		)	6,476		15,774		-			(9,000		)	6,774
Total Housewares	257,096		-			(9,289		)	247,807		257,105		-			(9,000		)	248,105
Healthcare / Home Environment:
Goodwill	250,802		-			-			250,802		250,867		-			-			250,867
Trademarks - indefinite	54,000		-			-			54,000		54,000		-			-			54,000
Licenses - finite	15,300		-			(1,234		)	14,066		14,900		-			(481		)	14,419
Other Intangibles - finite	114,490		-			(14,607		)	99,883		114,790		-			(11,741		)	103,049
Total Healthcare / Home Environment	434,592		-			(15,841		)	418,751		434,557		-			(12,222		)	422,335
Total	$	928,284	$	(46,490	)	$	(57,800	)	$	823,994	$	928,258	$	(46,490	)	$	(52,268	)	$	829,500

The following table summarizes the amortization expense attributable to intangible assets for the periods covered in the accompanying consolidated condensed statements of income, as well as our estimated amortization expense for the fiscal years 2013 through 2018.

AMORTIZATION OF INTANGIBLE ASSETS
(in thousands)
Aggregate Amortization Expense
For the three months ended
May 31, 2012	$	5,636
May 31, 2011	$	4,557
Estimated Amortization Expense
For the fiscal years ended
February 2013	$	22,190
February 2014	$	21,509
February 2015	$	20,945
February 2016	$	20,761
February 2017	$	20,423
February 2018	$	16,599

- 11 -

NOTE 9 - Acquisitions

PUR Acquisition - On December 30, 2011, we completed an asset and stock purchase transaction in which we acquired 100 percent of the stock of PUR Water Purification Products, Inc., and certain other assets and liabilities from The Procter & Gamble Company and certain of its affiliates (“P&G”) for a net cash purchase price of $160 million, subject to future adjustments.  The acquisition was funded entirely with short-term debt.  Significant assets acquired include manufacturing equipment, trademarks, customer lists, distribution rights, patents, and thegoodwill of the PUR water filtration business.  PUR’s product line includes faucet mount water filtration systems and filters, pitcher systems and filters, and refrigerator filters.  We are operating the PUR business in our Healthcare / Home Environment segment and market its products primarily into retail trade channels in the U.S.  Goodwill arising from the acquisition consists largely of the distribution network, marketing synergies and economies of scale that are anticipated from the addition of the new product line.

In connection with this acquisition, we entered into transitional services and supply agreements whereby P&G or one or more of its affiliates will provide certain short-term services for, and supply certain products to, the Company in exchange for specified fees. When we finish using certain of these services in the second quarter of fiscal 2013, we will acquire any remaining PUR inventory on-hand from P&G.

We accounted for the acquisition as the purchase of a business and recorded the excess purchase price as goodwill. None of the goodwill recognized is expected to be deductible for income tax purposes. We completed our preliminary estimate of the economic lives of all the assets acquired and a preliminary allocation of the initial purchase price. We assigned the acquired trademarks indefinite economic lives and are amortizing the customer list,  patents, trademarks and technology license agreements, and covenant not to compete over expected weighted average lives of approximately 15.0,  12.4,  5.2 and 2.0  years, respectively.  For the customer list, we used historical attrition rates to assign an expected life.  For patent rights, we used the underlying non-renewable term of a royalty-free license we acquired for the use of patented designs in certain PUR products. The trademarks acquired have indefinite lives that are not subject to amortization.

The following schedule presents the acquisition date fair value of the net assets of PUR:

PUR - NET ASSETS ACQUIRED ON DECEMBER 30, 2011

(in thousands)
Supplier tooling advances	$	1,432
Tools, dies, molds and other production equipment	12,495
Goodwill	86,162
Trademarks	54,000
Trademark and technology licensing agreements	14,900
Patents	4,140
Customer list	18,600
Covenant not to compete	200
Total assets acquired	191,929
Less: Deferred tax liabilities recorded at acquisition	(31,929		)
Net assets acquired	$	160,000

We estimated the fair values of the PUR assets acquired by applying income and market approaches. The fair value measurement of the intangible assets is based on significant inputs that are not observable in the market and, therefore, represent Level 3 measurements.  Key assumptions included various discount rates based upon a 15.20 percent weighted average cost of capital, a royalty rate of 7.0 percent used to determine the trademark fair value, royalty rates of 0.50 to 1.00 percent used to determine patent estate values, and customer attrition rates of 5.00 percent per year used to determine customer list value.

- 12 -

Note 10 – Debt

Revolving Line of Credit - We have a Credit Agreement (the “2010 RCA”) with Bank of America, N.A. that provides for an unsecured total revolving commitment of up to $250.00 million. The commitment under the 2010 RCA terminates on December 30, 2015.  Borrowings accrue interest under one of two alternative methods as described in the 2010 RCA.  We also incur loan commitment fees and letter of credit fees under the 2010 RCA.  Outstanding letters of credit reduce the borrowing availability under the 2010 RCA on a dollar-for-dollar basis.  As of May 31, 2012, the outstanding revolving loan principal balance was $158.00 million and there were $0.35 million of open letters of credit outstanding against the 2010 RCA. For the three months ended May 31, 2012 and May 31, 2011, borrowings under the 2010 RCA incurred interest charges at rates ranging from 1.61 to 4.00 percent and 1.95 to 4.00 percent, respectively. As of May 31, 2012, the amount available for borrowings under the 2010 RCA was $91.65 million.

Long-Term Debt – A summary of our long-term debt is as follows:

LONG-TERM DEBT

(dollars in thousands)
	Original
	Date	Interest		May 31,			February 29,
	Borrowed	Rates	Matures	2012			2012
$15 million unsecured Senior Note payable at a fixed interest rate of 7.24%. Interest payable quarterly. Annual principal payments of $3 million began in July 2008.	07/97	7.24%	07/12	$	3,000		$	3,000
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due at maturity. Notes can be prepaid without penalty. (1)	06/04	6.01%	06/14	75,000			75,000
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a “make whole” premium.	01/11	3.90%	01/18	100,000			100,000
Total long-term debt				178,000			178,000
Less current maturities of long-term debt				(3,000		)	(3,000		)
Long-term debt, excluding current maturities				$	175,000		$	175,000

(1)Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additionalinformation regarding the swap is provided in Note (12) to these consolidated condensed financial statements.

The fair market value of the fixed rate debt at May 31, 2012 computed using a discounted cash flow analysis was $104.43 million compared to the $103.00 million book value and represents a Level 2 liability. All other long-term debt has floating interest rates, and its book value approximates its fair value at May 31, 2012.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms is defined in the various agreements).  Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends.

As of May 31, 2012, our debt agreements effectively limited our ability to incur more than $251.80 million of additional debt from all sources, including draws on the 2010 RCA. As of May 31, 2012, we were in compliance with the terms of all of our debt agreements.

- 13 -

Note 11 – Fair Value

The fair value hierarchy of our financial assets and liabilities carried at fair value and measured on a recurring basis is as follows:

FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES

(in thousands)
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	May 31, 2012		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,431	$	1,431	$	-
Foreign currency contracts	382		-		382
Total assets	$	1,813	$	1,431	$	382
Liabilities:
Long-term debt - fixed rate (1)	$	104,430	$	-	$	104,430
Long-term debt - floating rate	75,000		-		75,000
Interest rate swap	7,671		-		7,671
Total liabilities	$	187,101	$	-	$	187,101
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	February 29, 2012		(Level 1)		(Level 2)
Assets:
Money market accounts	$	801	$	801	$	-
Note receivable (1)	737		-		737
Total assets	$	1,538	$	801	$	737
Liabilities:
Long-term debt - fixed rate (1)	$	104,450	$	-	$	104,450
Long-term debt - floating rate	75,000		-		75,000
Interest rate swap	8,553		-		8,553
Foreign currency contracts	163		-		163
Total liabilities	$	188,166	$	-	$	188,166

(1)Note receivable and debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

The carrying amounts of cash and cash equivalents, receivables, accounts payable, accrued expenses, and income taxes payable approximate fair value because of the short maturity of these items.

Money market accounts are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 1 assets.

We classify our note receivable, fixed and floating rate debt as Level 2 liabilities because the estimation of the fair market value of these financial assets requires the use of a discount rate based upon current market rates of interest for debt with comparable remaining terms. Such comparable rates are significant other observable market inputs. The fair market value of the note receivable was computed using a discounted cash flow analysis and a discount rate of 6.95 percent at February 29, 2012. The fair market value of the fixed rate debt was computed using a discounted cash flow analysis and discount rates, ranging from 0.29 to 3.50 percent at May 31, 2012 and

- 14 -

0.54 to 3.54 percent at February 29, 2012, depending on the term of the loan. All other long-term debt has floating interest rates, and its book value approximates its fair value as of the reporting date.

We use derivatives for hedging purposes and our derivatives are primarily foreign currency contracts and an interest rate swap. We determine the fair value of our derivative instruments based on Level 2 inputs in the fair value hierarchy.

The Company’s other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 assets. These assets are measured at fair value on a non-recurring basis as part of the Company’s impairment assessments and as circumstances require.

Note 12 – Financial Instruments and Risk Management

Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three month periods ended May 31, 2012 and 2011, approximately 17 and 20 percent, respectively, of our net sales revenue was in foreign currencies.  These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Japanese Yen, Australian Dollars, Chilean Pesos, Peruvian Soles, and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases.  In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses from remeasurement are recognized in SG&A.  For the three month periods ended May 31, 2012 and2011, we recorded net foreign exchange gains (losses), including the impact of currency hedges, of ($0.94) and ($0.15) million, respectively, in SG&A and $0.19 and ($0.04) million, respectively, in income tax expense.

We have historically hedged against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.

Interest Rate Risk – Interest on our outstanding debt as of May 31, 2012 is both floating and fixed.  Fixed rates are in place on $103.00 million of Senior Notes at rates ranging from 3.90 to 7.24 percent and floating rates are in place on $158.00 million in advances against our 2010 RCA and $75.00 million of Senior Notes due June 2014.  If short-term interest rates increase, we will incur higher interest rates on any outstanding balances under the 2010 RCA. The floating rate Senior Notes due June 2014 reset as described in Note 10, and have been effectively converted to fixed rate debt using an interest rate swap (the “swap”), as described below.

We manage our floating rate debt using an interest rate swap.  As of May 31, 2012, the swap converted an aggregate notional principal amount of $75.00 million from floating interest rate payments under our Senior Notes due June 2014 to fixed interest rate payments at 6.01 percent.  In the swap transaction, we maintain contracts to pay fixed rates of interest on an aggregate notional principal amount of $75.00 million at a rate of 5.11 percent on our Senior Notes due June 2014, while simultaneously receiving floating rate interest payments set at 0.47 percent as of May 31, 2012 on the same notional amounts.  The fixed rate side of the swap will not change over its life.  The floating rate payments are reset quarterly based on three-month LIBOR.  The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments.  The swap is used to reduce our risk of increased interest costs; however, when interest rates drop significantly below the swap rate, we lose the benefit that our floating rate debt would provide, if not managed with a swap. The swap is considered 100 percent effective.

- 15 -

The fair values of our various derivative instruments are as follows:

FAIR VALUES OF DERIVATIVE INSTRUMENTS

(in thousands)

May 31, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	120	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	2/2013	£	5,750	262		-		-
Subtotal					382		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,464		4,207
Total fair value					$	382	$	3,464	$	4,207
February 29, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	-	$	163	$	-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,531		5,022
Total fair value					$	-	$	3,694	$	5,022

The pre-tax effect of derivative instruments for the periods covered in the accompanying consolidated condensed financial statements are as follows:

PRE-TAX EFFECT OF DERIVATIVE INSTRUMENTS
(in thousands)
	Three Months Ended May 31,
	Gain \ (Loss)						Gain \ (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain \ (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2012			2011			Location	2012			2011			Location	2012		2011
Currency contracts - ordinary and cash flow hedges	$	910		$	(487	)	SG&A	$	26		$	(144	)	SG&A	$	35	$	(63	)
Interest rate swaps - cash flow hedges	(44		)	(2,442		)	Interest expense	(926		)	(1,526		)		-		-
Total	$	866		$	(2,929	)		$	(900	)	$	(1,670	)		$	35	$	(63	)

(1) The amounts shown represent the ineffective portion of the change in fair value of a cash flow hedge.

We expect gains of $0.38 million associated with foreign currency contracts and losses of $3.46 million associated with our interest rate swap, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle.

Counterparty Credit Risk - Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

- 16 -

Note 13 – Repurchase of Helen of Troy Common Stock

As of May 31, 2012, we are authorized by our Board of Directors to purchase up to 3,022,788 shares of common stock in the open market or through private transactions.  Our current equity compensation plans include provisions that allow for the “cashless exercise” of stock options by all plan participants. In a cashless exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Cashless exercises are accounted for by the Company as a purchase and retirement of shares.

For the periods covered in the accompanying consolidated condensed financial statements, there was no open market repurchase activity, however common stock option exercise and director stock compensation activity resulted in the following share repurchases:

SHARE REPURCHASES

	Three Months Ended May 31,
	2012		2011
Value of common stock received as exercise price of options
Number of shares	44,444		26,183
Aggregate market value of shares (in thousands)	$	1,476	$	837
Average price per share	$	33.20	$	31.98
Value of common stock received from director stock compensation activity
Number of shares	1,122		-
Aggregate market value of shares (in thousands)	$	37	$	-
Average price per share	$	32.88	$	-

Note 14 – Share-Based Compensation Plans

We have options outstanding under two expired and three active share-based compensation plans.

During the fiscal quarter ended May 31, 2012, the Company granted options to purchase 301,000 shares of common stock at exercise prices ranging from $32.52 to $34.72 per share to certain of our officers, employees and new hires.  The fair value of the options were estimated using the Black-Scholes option pricing model to estimate fair values ranging from $13.16 to $14.57 for grants with terms of four and five years.  The following assumptions were used for the grants: expected lives ranging from 4.05 to 4.35 years; risk free interest rates ranging from  0.61 to 0.86  percent; zero dividend yield; and expected volatilities ranging from 50.95 to 52.48 percent.

On March 1, 2012, the Company granted 3,750 shares of restricted stock to certain board members, having fair values at the date of grant of $32.88 per share for a total value granted of $0.12 million. The restricted stock awards vested immediately and were valued at the fair value of the Company’s common stock at the date of the grant.

On March 1, 2012, under the terms of his employment agreement, our Chief Executive Officer and President was granted 700,000 restricted stock units (the “Performance RSUs”), which may be earned in tranches based on the Company’s achievement of specified performance goals for fiscal years 2013, 2014 and 2015.  Any earned Performance RSUs are subject to additional time-based vesting requirements. Up to 100,000 and 200,000 Performance RSUs may be earned based on the Company’s achievement of the specified performance goals for fiscal years 2013 and 2014, respectively.  Up to 700,000 Performance RSUs (less the number of Performance RSUs previously earned, if any) may be earned based on the Company’s achievement of either the specified performance goal for fiscal year 2015 or the three year average performance goal for fiscal years 2013 through 2015.  The Performance RSUs had a fair value at the date of grant of $32.88 per share for a grant date fair value of  $23.02 million.  Compensation expense associated with

- 17 -

Performance RSUs is equal to the market value of our common stock on the date of the grant multiplied by the number of Performance RSUs vesting during any given period.  Expense for each tranche must be estimated until earned, subject to a probability assessment of achieving the performance criteria specified for the tranche. We are recording the expense for each tranche over the related service periods.

During the fiscal quarter ended May 31, 2012, employees exercised stock options to purchase 93,005 shares of common stock.

We recorded share-based compensation expense in SG&A for the periods covered in the accompanying consolidated condensed financial statements as follows:

SHARE-BASED PAYMENT EXPENSE

(in thousands, except per share data)

	Three Months Ended May 31,
	2012			2011
Stock options	$	547		$	466
Directors stock compensation	123			-
Performance based restricted stock awards and units	932			-
Share-based payment expense	1,602			466
Less income tax benefits	(265		)	(25		)
Share-based payment expense, net of income tax benefits	$	1,337		$	441
Earnings per share impact of share based payment expense:
Basic	$	0.04		$	0.01
Diluted	$	0.04		$	0.01

- 18 -

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion contains a number of forward-looking statements, all of which are based on current expectations. Actual results may differ materially due to a number of factors, including those discussed in Part I, Item 3. “Quantitative and Qualitative Disclosures about Market Risk” and “Information Regarding Forward Looking Statements” in this report and “Risk Factors” in the Company’s most recent annual report on Form 10-K and its other filings with the Securities and Exchange Commission (the “SEC”).  This discussion should be read in conjunction with our consolidated condensed financial statements included under Part I, Item 1 of this report.

OVERVIEW OF THE QUARTER’S RESULTS:

U.S. and global macroeconomic conditions continue to fuel consumer uncertainty.  Over our latest fiscal quarter, domestic and global economic indicators have signaled a slowing of the domestic economic recovery, parts of the Euro zone slipping back into recession and weakening overall world economic growth.  While gasoline prices have declined off recent highs and housing markets have stopped their downward trend in most major domestic markets, consumers are pulling back on discretionary purchases as evidenced by a decline in reported U.S. retail sales in April and May (after adjusting for declining gasoline prices).  Industrial production, exports and consumer confidence have declined in recent months as a result of daily coverage of European sovereign debt issues, weak employment reports and the potential U.S. fiscal impact of tax increases and spending cuts.  With demand for our products highly correlated to consumer sentiment, our ability to achieve our business plans is constrained by current economic conditions.  With the prospect of weak consumer demand, our competitors and customers across many businesses are beginning to push highly promotional pricing to keep shelf space and help entice consumers.  This pressure on our top line revenues, combined with cost pressures from our suppliers and the general economic uncertainties discussed above, continue to keep us cautious regarding our outlook for the remainder of fiscal 2013.

Consolidated net sales revenue for the three month period ended May 31, 2012 increased 10.6 percent to $300.21 million, compared to $271.47 million for the same period last year.  Net sales revenue in our Personal Care segment was down $5.17 million, or 4.2 percent, for the three month period ended May 31, 2012, when compared to the same period last year.  Net sales revenue in our Housewares segment was up $7.3 million, or 13.8 percent, for the three month period ended May 31, 2012, when compared to the same period last year.  Net sales revenue in our Healthcare / Home Environment segment was up $26.61 million, or 27.8 percent, for the three month period ended May 31, 2012, when compared to the same period last year.  The Healthcare / Home Environment segment’s results include $24.29 million of incremental net sales revenue from our PUR water filtration business, which was acquired from The Procter & Gamble Company and certain of its affiliates on December 30, 2011.  In addition to our net sales revenue performance discussed above, key results for the three month period ended May 31, 2012 include the following:

·     Consolidated gross profit margin as a percentage of net sales revenue decreased 0.1 percentage point to 40.4 percent for the three month period ended May 31, 2012 compared to 40.5 percent for the same period last year.

·     SG&A as a percentage of net sales revenue increased by 0.8 percentage points to 30.0 percent for the three month period ended May 31, 2012, compared to 29.2 percent for the same period last year.

·     Operating income was $31.15 million for the three month period ended May 31, 2012, compared to $30.65 million for the same period last year.

·     For the three month period ended May 31, 2012, our net income was $23.47 million compared to $24.61 million for the same period last year.  Our diluted earnings per share was $0.74 for the three month period ended May 31, 2012, compared to $0.78 for the same period last year.

- 19 -

RESULTS OF OPERATIONS

Comparison of the three month period ended May 31, 2012 to the three month period ended May 31, 2011

The following table sets forth, for the periods indicated, our selected operating data in U.S. Dollars, as a year-over-year percentage change and as a percentage of net sales revenue.

SELECTED OPERATING DATA

(dollars in thousands)

	Three Months Ended May 31,										% of Sales Revenue, net
	2012			2011			$ Change			% Change	2012		2011
Sales revenue, net
Personal Care	$	117,552		$	122,718		$	(5,166	)	-4.2%	39.2	%	45.2	%
Housewares	60,249			52,946			7,303			13.8%	20.1	%	19.5	%
Healthcare / Home Environment *	122,410			95,803			26,607			27.8%	40.8	%	35.3	%
Total sales revenue, net	300,211			271,467			28,744			10.6%	100.0	%	100.0	%
Cost of goods sold	179,063			161,554			17,509			10.8%	59.6	%	59.5	%
Gross profit	121,148			109,913			11,235			10.2%	40.4	%	40.5	%
Selling, general and administrative expense	90,000			79,259			10,741			13.6%	30.0	%	29.2	%
Operating income	31,148			30,654			494			1.6%	10.4	%	11.3	%
Nonoperating income (expense), net	23			143			(120		)	-83.9%	0.0	%	0.1	%
Interest expense	(3,312		)	(3,429		)	117			-3.4%	-1.1	%	-1.3	%
Total other income (expense)	(3,289		)	(3,286		)	(3		)	0.1%	-1.1	%	-1.2	%
Income before income taxes	27,859			27,368			491			1.8%	9.3	%	10.1	%
Income tax expense	4,387			2,763			1,624			58.8%	1.5	%	1.0	%
Net income	$	23,472		$	24,605		$	(1,133	)	-4.6%	7.8	%	9.1	%

   *  Includes three months of PUR net sales revenue in fiscal 2013 of $24.29 million

Consolidated net sales revenue:

Consolidated net sales revenue for the three month period ended May 31, 2012 increased 10.6 percent to $300.21 million, compared to $271.47 million for the same period last year.   Our Personal Care segment’s net sales revenue declined $5.17 million, or 4.2 percent, for the three month period ended May 31, 2012, when compared to the same period last year. Our Housewares segment’s net sales revenue increased $7.30 million, or 13.8 percent, for the three month period ended May 31, 2012, when compared to the same period last year. Our Healthcare / Home Environment segment’s net sales revenue increased $26.61 million, or 27.8 percent, for the three month period ended May 31, 2012, when compared to the same period last year.  The Healthcare / Home Environment segment’s results included incremental net sales revenue of $24.29 million from our recent acquisition of the PUR water filtration business on December 30, 2011.

Impact of acquisitions on net sales revenue:

Net sales revenue from the PUR acquisition contributed 8.9 percentage points, or $24.29 million, to our consolidated net sales revenue growth for the three month period ended May 31, 2012.  The PUR business operates as part of the Healthcare / Home Environment segment.  Organic growth from our core business (business owned and operated over the same fiscal period last year) contributed 1.6 percentage points, or $4.45 million, of consolidated net sales revenue growth for the three month period ended May 31, 2012, when compared to the same period last year.

- 20 -

The following table sets forth the impact acquisitions had on our net sales revenue:

IMPACT OF ACQUISITIONS ON NET SALES REVENUE

(in thousands)

	Three Months Ended May 31,
	2012		2011
Prior year’s sales revenue, net	$	271,467	$	160,153
Components of net sales revenue change
Core business	4,453		8,998
Incremental net sales revenue from acquisitions:
Pert Plus & Sure (one month in fiscal 2012)	-		6,513
Kaz (three months in fiscal 2012)	-		95,803
PUR (three months in fiscal 2013)	24,291		-
Change in sales revenue, net	28,744		111,314
Sales revenue, net	$	300,211	$	271,467
Total net sales revenue growth	10.6%		69.5%
Core business	1.6%		5.6%
Acquisitions	8.9%		63.9%

In the above table, core business is net sales revenue associated with product lines or brands after the first twelve months from the date a business, product line or brand was acquired. Net sales revenue from internally developed brands or product lines are always considered core business. Net sales revenue from acquisitions is net sales revenues associated with product lines or brands that we have acquired and operated for less than twelve months during each period presented.

Impact of foreign currencies on net sales revenue:

During the three month periods ended May 31, 2012 and 2011, we transacted approximately 17 and 20 percent, respectively, of our net sales revenues in foreign currencies. These were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Japanese Yen, Australian Dollars, Chilean Pesos, Peruvian Soles, and Venezuelan Bolivares Fuertes.  For the three month period ended May 31, 2012, the impact of net foreign currency exchange rates decreased our reported international net sales revenue by approximately $2.65 million.  Most of the impact of these fluctuations affected sales in our Personal Care and Healthcare / Home Environment segments.

Segment net sales revenue:

We operate our business under three segments: Personal Care, Housewares and Healthcare / Home Environment. Our Personal Care segment’s products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid, solid- and powder-based personal care and grooming products. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment focuses on health care devices such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances such as air purifiers, portable heaters, fans, and bug zappers.

Personal Care Segment - Net sales revenue in the Personal Care segment for the three month period ended May 31, 2012 decreased $5.17 million, or 4.2 percent, to $117.55 million compared with $122.72 million for the same period last year.  Modest overall net sales revenue gains in appliance and accessories categories were offset by declines in our grooming, skin care and hair care solutions product categories.   Personal Care net sales revenue was negatively impacted by the following factors:

·A difficult U.S. retail sales environment reflected in recent year-over-year sales declines reported by some of the major retailers;

- 21 -

·Challenging macroeconomic conditions in Europe and Latin America;

·Increases in competitive trade promotional activities, including a major hair category launch by a significant competitor;

·Product availability issues due primarily to the closure of a third-party supplier in the Far East; and

·The impact of foreign currency fluctuations on U.S. Dollar reported net sales.

We continue to expect that net sales revenue performance in our Personal Care segment will be heavily dependent on the direction of consumer sentiment, which requires continued improvements in employment, housing markets and consumers’ personal finances.

Housewares Segment – Net sales revenue in the Housewares segment for the three month period ended May 31, 2012 increased $7.30 million, or 13.8 percent, to $60.25 million compared with $52.95 million for the same period last year.  A portion of the Housewares segment’s growth came from aggressive seasonal closeout sales to improve the segment’s inventory position.  The remainder of the Housewares segment’s growth was fueled by price increases, new item sales and expanded distribution in the OXO tot baby and toddler category, shipments of new OXO POP container lines, and expanded international distribution.  As a result of the closeout sales activity, we believe that some level of sales have been concentrated in the three month period ended May 31, 2012 that might otherwise normally occur over the remainder of the fiscal year.  As such, we believe that the year-over-year growth achieved in the three month period ended May 31, 2012 will not be indicative of year-over-year growth for the full fiscal year 2013.  We currently believe net sales revenue annual growth rates for the segment will normalize around mid to high single digits over the remainder of fiscal 2013.

Healthcare / Home Environment – Net sales revenue in the Healthcare / Home Environment segment for the three month period ended May 31, 2012 increased $26.61 million, or 27.8 percent, to $122.41 million compared with $95.80 million for the same period last year.  The Healthcare / Home Environment segment’s results included incremental net sales revenue of $24.29 million from our recent acquisition of the PUR water filtration business on December 30, 2011.  Organic growth accounted for $2.32 million, or 2.4 percent, of the sales growth when compared to the same period last year, which was driven by increases in thermometer and fan shipments.  Sales gains were partially offset by the impact of high inventory levels at retail due to the warm winter and mild cold and flu season.

Consolidated gross profit margin:

Consolidated gross profit margin as a percentage of net sales revenue for the three months ended May 31, 2012 decreased 0.1 percentage point to 40.4 percent compared to 40.5 percent for the same period last year.  Our consolidated gross profit margin was unfavorably impacted by the combined effects of foreign currency exchange rates on net sales, increased air freight costs incurred in the Personal Care segment to mitigate product availability issues due primarily to the closure of a supplier, higher closeout sales in the Housewares segment, and general product cost increases across all segments.  These unfavorable impacts were mostly offset by the PUR water filtration acquisition, which had a favorable impact of 1.9 percentage points on consolidated gross profit margin.

Our product sourcing mix is heavily dependent on imports from China. China’s currency is no longer pegged solely to the U.S. dollar. As a result, we believe China’s currency will continue to appreciate against the U.S. Dollar in the short-to-intermediate-term, resulting in increased product costs over time.  Furthermore, if increases in the underlying costs of labor and commodities in China occur, we expect that they would also result in future increases in our product costs.

- 22 -

Selling, general and administrative expense:

SG&A increased 0.8 percentage points, or $10.74 million, to 30.0 percent of net sales revenue for the three month period ended May 31, 2012, compared to 29.2 percent for the same period last year. The year-over-year increase in SG&A as a percentage of net sales revenue is primarily due to:

·Higher media advertising costs to support the grooming, skin care and hair care solutions product categories and the PUR water filtration business;

·Transition service fees incurred during the fiscal quarter ended May 31, 2012 in connection with the acquisition of the PUR business, which we did not incur during the same fiscal quarter last year;

·Higher incentive compensation expense associated with a new performance bonus plan for our Chief Executive Officer;

·Higher depreciation as a result of an upgrade of our Enterprise Resource Planning system;

·Higher amortization of intangible assets as a result of the PUR acquisition; and

·The impact of revaluation losses from foreign currency exchange rate fluctuations.

Operating income (loss) by segment:

The following table sets forth, for the periods indicated, our operating income (loss) by segment as a year-over-year percentage change and as a percentage of net sales revenue for each segment and the Company overall:

OPERATING INCOME (LOSS) BY SEGMENT

(dollars in thousands)

	Three Months Ended May 31,									% of Sales Revenue, net
	2012		2011			$ Change			% Change	2012		2011
Personal Care	$	11,880	$	19,852		$	(7,972	)	-40.2%	10.1	%	16.2%
Housewares	11,277		10,865			412			3.8%	18.7	%	20.5%
Healthcare / Home Environment **	7,991		(63		)	8,054			*	6.5	%	-0.1%
Total operating income	$	31,148	$	30,654		$	494		1.6%	10.4	%	11.3%

*Calculation is not meaningful

**Includes three months of PUR operating income in fiscal 2013

We compute operating income for each segment based on net sales revenue, less cost of goods sold and any SG&A associated with the segment. The SG&A used to compute each segment’s operating income is comprised of SG&A directly associated with the segment, plus overhead expenses that are allocable to the segment.  We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facilities square footage.  In fiscal 2013, we began making certain additional cost allocations to the Healthcare / Home Environment segment that were not made in fiscal 2012.  These allocations are costs of corporate and operating functions that are shared by the segments.   We made this change because we now have a complete fiscal year’s operating experience with the Healthcare / Home Environment segment.  In the past year we have integrated certain of the segment’s corporate and operating functions that were redundant. For the three month period ended May 31, 2012, the allocation totaled $4.12 million compared to $1.50 million for the same period last year.

- 23 -

The Personal Care segment’s operating income decreased $7.97 million, or 40.2 percent, for the three month period ended May 31, 2012 compared to the same period last year.  The decline was principally due to:

·A difficult U.S. retail sales environment reflected in recent year-over-year sales declines reported by some of the major retailers;

·Challenging macroeconomic conditions in Europe and Latin America;

·Increases in competitive trade promotional activities, including a major hair category launch by a significant competitor;

·The impact of foreign currency fluctuations on U.S. Dollar reported net sales;

·Increased air freight costs incurred to mitigate the impact of product availability issues due primarily to the closure of a supplier;

·Product cost increases across most product categories;

·Higher media advertising;

·Higher depreciation as a result of an upgrade of our Enterprise Resource Planning system; and

·The impact of revaluation losses from foreign currency exchange rate fluctuations.

The Housewares segment’s operating income increased $0.42 million, or 3.8 percent, for the three month period ended May 31, 2012, when compared to the same period last year. The increase in operating income is principally due to an increase in net sales revenue partially offset by higher cost of goods sold as a result of costs increases and lower margin closeout sales.

The Healthcare / Home Environment segment’s operating income increased $8.05 million for the three month period ended May 31, 2012, when compared to the same period last year.  The increase in operating income was primarily due to the incremental impact of the PUR acquisition.  In addition, the segment’s core business experienced organic sales growth, gross margin improvement and a reduction in SG&A as a percentage of sales, which contributed to the segment’s increase in operating income.

Interest expense:

Interest expense for the three month period ended May 31, 2012 was $3.31 million compared to $3.43 million for the same period last year.  Interest expense was lower when compared to the same period last year despite higher levels of debt due to lower interest rates on short-term debt.

Income tax expense:

Income tax expense for the three month period ended May 31, 2012 was 15.7 percent of income before income taxes compared to 10.1 percent for the same period last year.  Over the past two fiscal years, our effective tax rates have been trending up primarily due to the acquisitions of Kaz and PUR, which increased the proportion of taxable income in higher tax rate jurisdictions relative to total taxable income.

- 24 -

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Selected measures of our liquidity and capital resources for the three month periods ended May 31, 2012 and 2011 are shown below:

SELECTED MEASURES OF OUR LIQUIDITY AND CAPITAL UTILIZATION

	Three Months Ended May 31,
	2012	2011
Accounts Receivable Turnover (Days) (1)	61.0	63.8
Inventory Turnover (Times) (1)	2.9	2.8
Working Capital (in thousands)	$143,203	$150,212
Current Ratio	1.4 : 1	1.5 : 1
Debt to Equity Ratio (2)	40.6%	40.0%
Return on Average Equity (1)	14.3%	15.1%

(1)  Accounts receivable turnover, inventory turnover and return on average equity computations use 12-month trailing sales, cost of sales or net income components as required by the particular measure.   The current and four prior quarters’ ending balances of accounts receivable, inventory, and equity are used for the purposes of computing the average balance component as required by the particular measure.

(2)  Debt is defined as all debt outstanding at the balance sheet date. This includes the sum of the following lines on our consolidated balance sheets: “Revolving line of credit,” “Long-term debt, current maturities” and “Long-term debt, excluding current maturities.”

Operating activities:

Operating activities provided $9.02 million of cash during the first three months of fiscal 2012, compared to $4.42 million of cash provided during the same period in fiscal 2011.  The increase in operating cash flow was primarily due to the timing of fluctuations in working capital components, when compared to the same period last year.

Accounts receivable decreased $7.02 million to $188.26 million as of May 31, 2012, compared to $195.28 million at the end of fiscal 2012.  Accounts receivable turnover improved to 61.0 days at May 31, 2012 from 63.8 days at May 31, 2011.  This calculation is based on a rolling five quarter accounts receivable balance.

Inventories increased $13.85 million to $259.99 million as of May 31, 2012, compared to $246.14 million at the end of fiscal 2012.  Inventory turnover was 2.9 times at May 31, 2012 compared to 2.8 times at May 31, 2011. Inventories as of May 31, 2012 increased $31.75 million, when compared to May 31, 2011.  The increase is primarily due to the warm winter and mild cold and flu season’s negative impact on our Healthcare / Home Environment segment shipments.

Working capital was $143.20 million at May 31, 2012, compared to $150.21 million at May 31, 2011.  Our current ratio decreased to 1.4:1 at May 31, 2012, compared to 1.5:1 at May 31, 2011.

Investing activities:

Investing activities used $2.62 million of cash during the three month period ended May 31, 2012. Highlights of those activities follow:

·We spent $0.94 million on molds and tooling, $2.15 million on information technology infrastructure, $0.10 million on the development of new patents, and $0.18 million on other capital asset additions; and

·We received proceeds of $0.74 million on a note receivable associated with the fiscal 2012 sale of a land parcel in El Paso, Texas.

- 25 -

Financing activities:

Financing activities used $7.36 million of cash during the three month period ended May 31, 2012.  Highlights of those activities follow:

·We had draws of $59.95 million against our revolving credit agreement;

·We repaid $73.05 million drawn against our revolving credit agreement;

·Employees exercised options to purchase 93,005 shares of common stock, providing $0.67 million of cash; and

·Tax benefits associated with the exercise of options provided $4.87 million of cash.

Revolving Line of Credit Agreement and Other Debt Agreements:

We have a Credit Agreement (the “2010 RCA”) with Bank of America, N.A. that provides for an unsecured total revolving commitment of up to $250.00 million. The commitment under the 2010 RCA terminates on December 30, 2015.  Borrowings under the 2010 RCA accrue interest at a “Base Rate” plus a margin of 0.00 to 1.125 percent per annum based on the Leverage Ratio (as defined in the 2010 RCA) at the time of borrowing. The base rate is equal to the highest of the Federal Funds Rate (as defined in the 2010 RCA) plus 0.50 percent, Bank of America’s prime rate or the one-month LIBOR rate plus 1.00 percent. Alternatively, if we elect, borrowings accrue interest based on the respective 1-, 2-, 3-, or 6-month LIBOR rate plus a margin of 1.00 to 2.125 percent per annum based upon the Leverage Ratio at the time of the borrowing. We also incur loan commitment fees and letter of credit fees under the 2010 RCA.  Outstanding letters of credit reduce the borrowing availability under the 2010 RCA on a dollar-for-dollar basis.  As of May 31, 2012, the revolving loan principal balance was $158.00 million and there were $0.35 million of open letters of credit outstanding against the 2010 RCA. For the three months ended May 31, 2012 and May 31, 2011, borrowings under the 2010 RCA incurred interest charges at rates ranging from 1.61to 4.00 percent and 1.95 to 4.00 percent, respectively. As of May 31, 2012, the amount available for borrowings under the 2010 RCA was $91.65 million.

In addition to the 2010 RCA, at May 31, 2012, we had an aggregate principal balance of $178.00 million of  Senior Notes from prior year’s financings with varying maturities due between June 2012 and January 2018 and interest rates ranging from 3.90 to 7.24 percent. Up to $75.00 million of the debt can be prepaid without penalty while $103.00 million of the debt is subject to a “make-whole” premium if repaid before maturity.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries.  Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms are defined in the various agreements).  Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends. Our debt agreements also contain customary events of default, including failure to pay principal or interest when due, among others. Our debt agreements are cross-defaulted to each other. Upon an event of default under our debt agreements, the holders or lenders may, among other things, accelerate the maturity of any amounts outstanding under our debt. Under the terms of our 2010 RCA, the commitments of the lenders to make loans to us are several and not joint. Accordingly, if any lender fails to make loans to us, our available liquidity could be reduced by an amount up to the aggregate amount of such lender’s commitments under the facility.

- 26 -

The table below provides the formulas for certain key financial covenants as defined in our various debt agreements:

Applicable Financial Covenant	2010 RCA	$75 Million Floating Rate Senior Notes	$100 Million 3.90% Fixed Rate Senior Notes and $3 Million 7.24% Fixed Rate Senior Notes
Minimum Consolidated Net Worth	$530 Million + 100% of Increase in Equity Due to Sale of Equity Interests After August 31, 2010 + 40% of Fiscal Quarter Net Earnings After August 31, 2010 (1)	$260 Million + 25% of Fiscal Quarter Net Earnings After February 29, 2004 (1)	$500 Million + 25% of Fiscal Quarter Net Earnings After August 31, 2010 (1)
Interest Coverage Ratio	EBIT (2) ÷ Interest Expense (2)	None	EBIT (2) ÷ Interest Expense (2)
	Minimum Required: 3.00 to 1.00		Minimum Required: 2.50 to 1.00
Maximum Leverage Ratio	Total Current and Long Term Debt (3) ÷ [EBITDA (2) + Pro Forma Effect of Acquisitions]	Total Current and Long Term Debt (3) ÷ Total Capitalization (3)	Total Current and Long Term Debt (3) ÷ [ EBITDA (2) + Pro Forma Effect of Acquisitions ]
	Maximum Allowed: 3:00 to 1:00	Maximum Allowed: 55%	Maximum Allowed: 3:25 to 1:00

Key Definitions:
EBIT:	Earnings Before Non-Cash Charges, Interest Expense and Taxes
EBITDA:	EBIT + Depreciation and Amortization Expense + Share Based Compensation
Total Capitalization:	Total Current and Long Term Debt + Total Equity
Pro Forma Effect of Acquisitions:	For any acquisition, pre-acquisition EBITDA of the acquired business is included so that the EBITDA of the acquired business included in the computation equals its twelve month trailing total.

Notes:

(1) Excluding any fiscal quarter net losses.

(2) Computed using totals for the latest reported four consecutive fiscal quarters.

(3) Computed using the ending balances as of the latest reported fiscal quarter.

As of May 31, 2012, all our debt agreements effectively limited our ability to incur more than an estimated $251.80 million of additional debt from all sources, including draws on the 2010 RCA. We are currently in compliance with the terms of our debt agreements.

- 27 -

Contractual obligations and commercial commitments:

Our contractual obligations and commercial commitments at May 31, 2012, were:

PAYMENTS DUE BY PERIOD - TWELVE MONTHS ENDED MAY 31:

(in thousands)

			2013		2014		2015		2016		2017		After
	Total		1 year		2 years		3 years		4 years		5 years		5 years
Term debt - fixed rate	$	103,000	$	3,000	$	20,000	$	20,000	$	20,000	$	20,000	$	20,000
Term debt - floating rate (1)	75,000		-		-		75,000		-		-		-
Long-term incentive plan payouts	5,391		2,763		1,481		971		176		-		-
Interest on fixed rate debt	14,132		3,927		3,601		2,821		2,041		1,261		481
Interest on floating rate debt (1)	9,374		4,508		4,508		358		-		-		-
Open purchase orders	207,477		207,477		-		-		-		-		-
Minimum royalty payments	100,515		15,030		13,448		13,005		11,924		10,273		36,835
Advertising and promotional	81,204		16,178		6,208		6,096		6,282		6,474		39,966
Operating leases	20,111		5,145		4,402		4,477		2,909		1,423		1,755
Capital spending commitments	3,695		3,695		-		-		-		-		-
Total contractual obligations (2)	$	619,899	$	261,723	$	53,648	$	122,728	$	43,332	$	39,431	$	99,037

(1)	The Company uses an interest rate hedge agreement (the “swap”), in conjunction with its unsecured, floating interest rate, $75.00 million Senior Notes due June 2014. The swap hedges the variable LIBOR rates used to reset the floating rates on these Senior Notes. The swap effectively fixes the interest rates on the Senior Notes due June 2014 at 6.01 percent.
(2)	In addition to the contractual obligations and commercial commitments in the table above, as of May 31, 2012, we have recorded a provision for our uncertain tax positions of $13.28 million. We are unable to reliably estimate the timing of future payments, if any, related to uncertain tax positions. Therefore, we have excluded these tax liabilities from the table above.

During fiscal 2012, we entered into an Amended and Restated Employment Agreement with Gerald J. Rubin, our Chief Executive Officer and President (the “Revised Employment Agreement”) and adopted the Helen of Troy Limited 2011 Annual Incentive Plan (the “2011 Bonus Plan”). The 2011 Bonus Plan was approved by our shareholders at our Annual General Meeting held on October 11, 2011. The base and incentive compensation provisions of the Revised Employment Agreement are effective for fiscal years 2013 through 2015, subject to earlier termination by either party. Substantially all of Mr. Rubin’s compensation pursuant to the Revised Employment Agreement is performance-based and contingent upon our achievement of specified performance targets.  Pursuant to the Revised Employment Agreement, Mr. Rubin received a grant of 700,000 restricted stock units (the “Performance RSUs”), which may be earned in tranches based on the Company’s achievement of specified performance goals for fiscal years 2013, 2014 and 2015.  Any earned Performance RSUs are subject to additional time-based vesting requirements. Up to 100,000 and 200,000 Performance RSUs may be earned based on the Company’s achievement of the specified performance goals for fiscal years 2013 and 2014, respectively. Up to 700,000 Performance RSUs (less the number of Performance RSUs previously earned, if any) may be earned based on the Company’s achievement of either the specified performance goal for fiscal year 2015 or the three-year average performance goal for fiscal years 2013 through 2015.  The Performance RSUs had a fair value at the date of grant of $32.88 per share for a grant date fair value of  $23.02 million.  Compensation expense associated with Performance RSUs is equal to the market value of our common stock on the date of the grant multiplied by the number of Performance RSUs vesting during any given period.  Expense for each tranche must be estimated until earned, subject to a probability assessment of achieving the performance criteria specified for the tranche. We are recording the expense for each tranche over the related service periods.

Mr. Rubin is also eligible to receive an annual bonus, subject to the achievement of specified performance targets.  Any such bonus that is earned and payable will be paid two-thirds in the form of cash or cash equivalents up to a maximum of $10.00 million. The remainder will be paid in the form of restricted stock. Any restricted stock

- 28 -

granted will vest, with respect to annual bonuses for fiscal years 2013 and 2014, on February 28, 2015, and with respect to annual bonus for fiscal year 2015, on the date the Company certifies that the performance goals have been achieved.  Additionally, under the Revised Employment Agreement, three life insurance policies and the obligation to pay the associated premiums will be transferred to Mr. Rubin over the term of the agreement subject to the Company meeting certain performance conditions.  The amount of the value of the transfer of each of the three life insurance policies (based on cash surrender values) is capped at $3.00, $4.00 and $7.00 million, respectively.

We currently expect Mr. Rubin to achieve certain performance targets for fiscal 2013 and the accompanying consolidated condensed financial statements include estimated accruals for his Performance RSU’s, annual bonus and life insurance bonus under the Revised Employment Agreement.  At this time we are unable to predict with a reasonable degree of certainty whether Mr. Rubin will achieve the performance targets for fiscal years 2014 and 2015. To the extent these performance targets are achieved (in full or in part), the resulting incentive compensation expense could have a significant impact upon future SG&A and net income.

Off-balance sheet arrangements:

We have no existing activities involving special purpose entities or off-balance sheet financing.

Current and future capital needs:

Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements.  We expect our capital needs to stem primarily from the need to purchase sufficient levels of inventory and to carry normal levels of accounts receivable on our balance sheet. In addition, we continue to evaluate acquisition opportunities on a regular basis and may augment our internal growth with acquisitions of complementary businesses or product lines. We may finance acquisition activity with available cash, the issuance of common stock, additional debt, or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition.

In addition to repurchases of shares associated with the net settlement of director and employee stock options, the Company may elect to repurchase additional common stock from time to time based upon its assessment of its liquidity position and market conditions at the time, and subject to limitations contained in its debt agreements.  For additional information, see Part II, Item 2. “Unregistered Sales of Equity Securities and Use of Proceeds” in this report.

CRITICAL ACCOUNTING POLICIES

The SEC defines critical accounting policies as those that are both most important to the portrayal of a company’s financial condition and results, and require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our critical accounting policies, see Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, under the heading “Critical Accounting Policies” in our annual report on Form 10-K for the year ended February 29, 2012. There have been no material changes to the Company’s critical accounting policies from the information provided in our annual report on Form 10-K.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 2 – “New Accounting Pronouncements,” to the accompanying consolidated condensed financial statements of this report, for a discussion of the status and potential impact of new accounting pronouncements.

- 29 -

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Changes in currency exchange rates and interest rates are our primary financial market risks.

Foreign currency risk:

Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three month periods ended May 31, 2012 and 2011, approximately 17 and 20 percent, respectively, of our net sales revenue was in foreign currencies.  These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Japanese Yen, Australian Dollars, Chilean Pesos, Peruvian Soles, and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases.  In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses from remeasurement are recognized in SG&A.

A significant portion of the products we sell are purchased from third-party manufacturers in China. During fiscal 2012 and 2011, the Chinese Renminbi appreciated against the U.S. Dollar approximately 4 percent each period. To the extent the Chinese Renminbi appreciates with respect to the U.S. Dollar in the future, the Company may experience cost increases on such purchases, and this can adversely impact profitability. China’s currency intervention strategy with respect to the U.S. Dollar continues to evolve. Future interventions by China may result in further currency appreciation and increase our product costs over time.

We identify foreign currency risk by regularly monitoring our foreign currency-denominated transactions and balances.  Where operating conditions permit, we reduce foreign currency risk by purchasing most of our inventory with U.S. Dollars and by converting cash balances denominated in foreign currencies to U.S. Dollars.

We have historically hedged against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  In these transactions, we execute a forward currency contract that will settle at the end of a forecasted period.  Because the size and terms of the forward contract are designed so that its fair market value will move in the opposite direction and approximate magnitude of the underlying foreign currency’s forecasted exchange gain or loss during the forecasted period, a hedging relationship is created.  To the extent that we forecast the expected foreign currency cash flows from the period we enter into the forward contract until the date it will settle with reasonable accuracy, we significantly lower or materially eliminate a particular currency’s exchange risk exposure over the life of the related forward contract.  We enter into these types of agreements where we believe we have meaningful exposure to foreign currency exchange risk and the hedge pricing appears reasonable.  It is not practical for us to hedge all our exposures, nor are we able to project in any meaningful way, the possible effect and interplay of all foreign currency fluctuations on translated amounts or future earnings.  This is due to our constantly changing exposure to various currencies, the fact that each foreign currency reacts differently to the U.S. Dollar and the significant number of currencies involved. Accordingly, we will always be subject to foreign exchange rate-risk on exposures we have not hedged, and these risks may be material.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.  We expect that as currency market conditions warrant, and our foreign denominated transaction exposure grows, we will continue to execute additional contracts in order to hedge against certain potential foreign exchange losses.

Interest rate risk:

Interest on our outstanding debt as of May 31, 2012 is both floating and fixed.  Fixed rates are in place on $103.00 million of Senior Notes at rates ranging from 3.90 to 7.24 percent and floating rates are in place on $158.00 million in advances against our 2010 RCA and $75.00 million of Senior Notes due June 2014.  If short-

- 30 -

term interest rates increase, we will incur higher interest rates on any outstanding balances under the 2010 RCA. The floating rate Senior Notes due June 2014 reset as described in Note 10 to the accompanying consolidated condensed financial statements, and have been effectively converted to fixed rate debt using an interest rate swap, as described below.

Our levels of debt, certain additional draws against the 2010 RCA (whose interest rates can vary with the term of each draw) and the uncertainty regarding the level of future interest rates increase our risk profile.  We manage our floating rate debt using an interest rate swap.  As of May 31, 2012, the swap converted an aggregate notional principal amount of $75.00 million from floating interest rate payments under our Senior Notes due June 2014 to fixed interest rate payments at 6.01 percent.  In the swap transaction, we maintain contracts to pay fixed rates of interest on an aggregate notional principal amount of $75.00 million at a rate of 5.11 percent on our Senior Notes due June 2014, while simultaneously receiving floating rate interest payments set at 0.47 percent as of May 31, 2012 on the same notional amounts.  The fixed rate side of the swap will not change over its life.  The floating rate payments are reset quarterly based on three-month LIBOR.  The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments.  The swap is used to reduce our risk of increased interest costs; however, when interest rates drop significantly below the swap rate, we lose the benefit that our floating rate debt would provide, if not managed with a swap. The swap is considered 100 percent effective.

The fair values of our various derivative instruments are as follows:

FAIR VALUES OF DERIVATIVE INSTRUMENTS

(in thousands)

May 31, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	120	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	2/2013	£	5,750	262		-		-
Subtotal					382		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,464		4,207
Total fair value					$	382	$	3,464	$	4,207
February 29, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	-	$	163	$	-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,531		5,022
Total fair value					$	-	$	3,694	$	5,022

Counterparty credit risk:

Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

- 31 -

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

Certain written and oral statements made by our Company and subsidiaries of our Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this report, in other filings with the Securities and Exchange Commission (“SEC”), in press releases, and in certain other oral and written presentations. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “continue”, “intends”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate will occur in the future, including statements related to sales, earnings per share results and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include, but are not limited to, the risks described in Part 1, Item 1A. “Risk Factors” of our annual report on Form 10-K for the year ended February 29, 2012 and risks otherwise described from time to time in our SEC reports as filed.  Such risks, uncertainties and other important factors include, among others:

·the departure and recruitment of key personnel;

·our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;

·our geographic concentration of certain U.S. distribution facilities, which at certain times operate at or near capacity, increases our exposure to significant shipping disruptions and added shipping and storage costs;

·our projections of product demand, sales and net income (including the Company’s guidance for PUR net sales revenue and the expectation that the acquisition will be accretive) are highly subjective in nature and future sales and net income could vary in a material amount from such projections;

·expectations regarding the acquisition of Kaz, PUR and any other future acquisitions, including our ability to realize anticipated cost savings, synergies and other benefits along with our ability to effectively integrate acquired businesses;

·our relationship with key customers and licensors;

·the costs of complying with the business demands and requirements of large sophisticated customers;

·our dependence on foreign sources of supply and foreign manufacturing, and associated operational risks including but not limited to long lead times, consistent local labor availability and capacity, and timely availability of sufficient shipping carrier capacity;

·the impact of changing costs of raw materials and energy on cost of goods sold and certain operating expenses;

·circumstances which may contribute to future impairment of goodwill, intangible or other long-lived assets;

·the risks associated with the use of trademarks licensed from and to third parties;

·our dependence on the strength of retail economies and vulnerabilities to a prolonged economic downturn;

·our ability to develop and introduce a continuing stream of new products to meet changing consumer preferences;

·disruptions in U.S., Euro zone and other international credit markets;

·foreign currency exchange rate fluctuations;

·trade barriers, exchange controls, expropriations, and other risks associated with foreign operations;

- 32 -

·our leverage and the constraints it may impose on our ability to manage our cash resources and operate our business;

·the costs, complexity and challenges of upgrading and managing our global information systems;

·the risks associated with information security breaches;

·the risks associated with tax audits and related disputes with taxing authorities;

·the risks of potential changes in laws, including tax laws and the complexities of compliance with such laws; and

·our ability to continue to avoid classification as a controlled foreign corporation.

We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

- 33 -

ITEM 4. CONTROLS AND PROCEDURES

DISCLOSURE CONTROLS AND PROCEDURES

Our management, under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), maintains disclosure controls and procedures as defined in Rules 13a-15(e) under the Exchange Act that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosures. Because of inherent limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

Our management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended May 31, 2012.   Based upon that evaluation, the CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable level of assurance as of May 31, 2012, the end of the period covered by this quarterly report on Form 10-Q.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

In connection with the evaluation described above, we identified no change in our internal control over financial reporting as defined in Rule 13a-15(f) that occurred during our fiscal quarter ended May 31, 2012, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

- 34 -

PART II.   OTHER INFORMATION

ITEM 1.   LEGAL PROCEEDINGS

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

ITEM 1A.   RISK FACTORS

The ownership of our common stock involves a number of risks and uncertainties.  When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part 1, Item 1A. “Risk Factors” of our annual report on Form 10-K for the fiscal year ended February 29, 2012.  Since the filing of our annual report on Form 10-K, there have been no material changes in our risk factors from those disclosed therein.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On October 11, 2011, our Board of Directors approved a resolution to add 3,000,000 shares to the then-existing shares of common stock authorized for repurchase in open market or through private transactions. On October 31, 2011, our Board of Directors approved a resolution to extend our existing repurchase program through October 31, 2014.  Under this program, as of May 31, 2012, we are authorized by our Board of Directors to purchase up to 3,022,788 shares of common stock in the open market or through private transactions.  Our current equity compensation plans include provisions that allow for the “cashless exercise” of stock options by all plan participants. In a cashless exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Cashless exercises are accounted for by the Company as a purchase and retirement of shares.

During the three month period ended May 31, 2012 there was no open market repurchase activity, however, employees tendered 44,444 shares of common stock having an aggregate market value of $1.48 million, or an average of $33.20 per share, as payment for the exercise price arising from the exercise of options. Also, during the three month period ended May 31, 2012, directors tendered 1,122 shares of common stock having an aggregate market value of $0.04 million, or an average of $32.88 per share, in exchange for cash in connection with certain director stock compensation activity.  We accounted for this activity as a purchase and retirement of the shares.  The following schedule sets forth the purchase activity for the three month period ended May 31, 2012:

ISSUER PURCHASES OF EQUITY SECURITIES FOR THE THREE MONTHS ENDED MAY 31, 2012
Period	Total Number of Shares Purchased	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
March 1 through March 31, 2012	10,430	$34.61	10,430	3,057,924
April 1 through April 30, 2012	1,739	34.15	1,739	3,056,185
May 1 through May 31, 2012	33,397	32.70	33,397	3,022,788
Total	45,566	$33.19	45,566

- 35 -

ITEM 6.      EXHIBITS

(a)Exhibits

10.1†		Restricted Stock Unit Agreement between the Company and Gerald J. Rubin, dated March 1, 2012 (incorporated by reference to Exhibit 10.32 to the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission for the year ending February 29, 2012).
31.1*		Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**		Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**			XBRL Instance Document
101.SCH**			XBRL Taxonomy Extension Schema
101.CAL**			XBRL Taxonomy Extension Calculation Linkbase
101.DEF**			XBRL Taxonomy Extension Definition Linkbase
101.LAB**			XBRL Taxonomy Extension Label Linkbase
101.PRE**			XBRL Taxonomy Extension Presentation Linkbase
†	Management contracts or compensatory plans or arrangements.
*	Filed herewith.
**	Furnished herewith. With respect to Exhibit 101, as provided by Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934.

- 36 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		HELEN OF TROY LIMITED
		(Registrant)
Date:	July 10, 2012	/s/ Gerald J. Rubin
		Gerald J. Rubin
		Chairman of the Board, Chief
		Executive Officer, President, Director
		and Principal Executive Officer
Date:	July 10, 2012	/s/ Thomas J. Benson
		Thomas J. Benson
		Senior Vice President
		and Chief Financial Officer
Date:	July 10, 2012	/s/ Richard J. Oppenheim
		Richard J. Oppenheim
		Financial Controller
		and Principal Accounting Officer

- 37 -

Index to Exhibits

10.1†	Restricted Stock Unit Agreement between the Company and Gerald J. Rubin, dated March 1, 2012 (incorporated by reference to Exhibit 10.32 to the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission for the year ending February 29, 2012).
31.1*	Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32**	Joint Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**	XBRL Instance Document
101.SCH**	XBRL Taxonomy Extension Schema
101.CAL**	XBRL Taxonomy Extension Calculation Linkbase
101.DEF**	XBRL Taxonomy Extension Definition Linkbase
101.LAB**	XBRL Taxonomy Extension Label Linkbase
101.PRE**	XBRL Taxonomy Extension Presentation Linkbase

†	Management contracts or compensatory plans or arrangements.
*	Filed herewith.
**	Furnished herewith. With respect to Exhibit 101, as provided by Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934.

- 38 -

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Gerald J. Rubin, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended May 31, 2012 of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:July 10, 2012

/s/ Gerald J. Rubin

Gerald J. Rubin

Chairman of the Board, Chief Executive Officer, President, Director

and Principal Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Thomas J. Benson, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended May 31, 2012 of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:July 10, 2012

/s/ Thomas J. Benson

Thomas J. Benson

Senior Vice President and Chief Financial Officer

EX-32

EXHIBIT 32

CERTIFICATION

In connection with the quarterly report of Helen of Troy Limited (the “Company”) on Form 10-Q for the fiscal quarter ended May 31, 2012, as filed with the Securities and Exchange Commission (the “Report”), and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, the Chairman, Chief Executive Officer, President, Director and Principal Executive Officer and the Senior Vice President and Chief Financial Officer of the Company, hereby certifies that to the best of their knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:July 10, 2012

/s/ Gerald J. Rubin

Gerald J. Rubin

Chairman of the Board, Chief Executive Officer, President, Director

and Principal Executive Officer

/s/ Thomas J. Benson

Thomas J. Benson

Senior Vice President and Chief Financial Officer

This certification is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933 or Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

XML

Goodwill and Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011	Feb. 29, 2012
Changes in Goodwill
Cumulative Goodwill Impairments	$ (46,490)		$ (46,490)
Goodwill Net Book Value	452,285		452,350
Changes in intangible assets - finite
Intangible assets - finite, Accumulated Amortization	(57,800)		(52,268)
Goodwill and intangible assets
Gross Carrying Amount	928,284		928,258
Net Book Value	823,994		829,500
Aggregate Amortization Expense	5,636	4,557
Estimated Amortization Expense
February 2013	22,190
February 2014	21,509
February 2015	20,945
February 2016	20,761
February 2017	20,423
February 2018	16,599
Personal Care
Changes in Goodwill
Goodwill Gross Carrying Amount	81,842		81,842
Cumulative Goodwill Impairments	(46,490)		(46,490)
Goodwill Net Book Value	35,352		35,352
Changes in intangible assets - finite
Intangible assets - finite, Accumulated Amortization	(32,670)		(31,046)
Goodwill and intangible assets
Gross Carrying Amount	236,596		236,596
Net Book Value	157,436		159,060
Personal Care | Trademarks - finite
Changes in intangible assets - finite
Intangible assets - finite, Gross Carrying Amount	150		150
Intangible assets - finite, Accumulated Amortization	(68)		(67)
Intangible assets - finite, Net Book Value	82		83
Personal Care | Licenses - finite
Changes in intangible assets - finite
Intangible assets - finite, Gross Carrying Amount	19,564		19,564
Intangible assets - finite, Accumulated Amortization	(16,097)		(15,967)
Intangible assets - finite, Net Book Value	3,467		3,597
Personal Care | Other Intangibles - finite
Changes in intangible assets - finite
Intangible assets - finite, Gross Carrying Amount	49,437		49,437
Intangible assets - finite, Accumulated Amortization	(16,505)		(15,012)
Intangible assets - finite, Net Book Value	32,932		34,425
Personal Care | Trademarks - indefinite
Changes in intangible assets - indefinite
Intangible assets - indefinite, Gross Carrying Amount	75,303		75,303
Personal Care | Licenses - indefinite
Changes in intangible assets - indefinite
Intangible assets - indefinite, Gross Carrying Amount	10,300		10,300
Housewares
Changes in Goodwill
Goodwill Gross Carrying Amount	166,131		166,131
Goodwill Net Book Value	166,131		166,131
Changes in intangible assets - finite
Intangible assets - finite, Accumulated Amortization	(9,289)		(9,000)
Goodwill and intangible assets
Gross Carrying Amount	257,096		257,105
Net Book Value	247,807		248,105
Housewares | Other Intangibles - finite
Changes in intangible assets - finite
Intangible assets - finite, Gross Carrying Amount	15,765		15,774
Intangible assets - finite, Accumulated Amortization	(9,289)		(9,000)
Intangible assets - finite, Net Book Value	6,476		6,774
Housewares | Trademarks - indefinite
Changes in intangible assets - indefinite
Intangible assets - indefinite, Gross Carrying Amount	75,200		75,200
Healthcare/Home Environment
Changes in Goodwill
Goodwill Gross Carrying Amount	250,802		250,867
Goodwill Net Book Value	250,802		250,867
Changes in intangible assets - finite
Intangible assets - finite, Accumulated Amortization	(15,841)		(12,222)
Goodwill and intangible assets
Gross Carrying Amount	434,592		434,557
Net Book Value	418,751		422,335
Healthcare/Home Environment | Licenses - finite
Changes in intangible assets - finite
Intangible assets - finite, Gross Carrying Amount	15,300		14,900
Intangible assets - finite, Accumulated Amortization	(1,234)		(481)
Intangible assets - finite, Net Book Value	14,066		14,419
Healthcare/Home Environment | Other Intangibles - finite
Changes in intangible assets - finite
Intangible assets - finite, Gross Carrying Amount	114,490		114,790
Intangible assets - finite, Accumulated Amortization	(14,607)		(11,741)
Intangible assets - finite, Net Book Value	99,883		103,049
Healthcare/Home Environment | Trademarks - indefinite
Changes in intangible assets - indefinite
Intangible assets - indefinite, Gross Carrying Amount	$ 54,000		$ 54,000

XML

Repurchase of Helen of Troy Common Stock (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Repurchase of Helen of Troy Common Stock
Shares authorized for purchase in the open market or through private transactions	3,022,788
Stock option
Repurchase of common stock
Common stock repurchased and retired (in shares)	44,444	26,183
Common stock repurchased and retired, total purchase price or aggregate market value	$ 1,476	$ 837
Average price per share (in dollars per share)	$ 33.20	$ 31.98
Restricted stock | Director
Repurchase of common stock
Common stock repurchased and retired (in shares)	1,122
Common stock repurchased and retired, total purchase price or aggregate market value	$ 37
Average price per share (in dollars per share)	$ 32.88

XML

Financial Instruments and Risk Management (Details 3) (Designated as cash flow hedging instruments, USD $) In Thousands, unless otherwise specified	May 31, 2012	Feb. 29, 2012
Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative Liabilities	$ 3,464	$ 3,694
Other Liabilities, Noncurrent
Fair values of derivative instruments in the consolidated balance sheet
Derivative Liabilities	4,207	5,022
Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	382
Foreign currency contracts | Canadian
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount	7,000	7,000
Foreign currency contracts | Canadian | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative Liabilities		163
Foreign currency contracts | Canadian | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	120
Foreign currency contracts | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount	5,750
Foreign currency contracts | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	262
Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount	75,000	75,000
Interest rate swaps | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative Liabilities	3,464	3,531
Interest rate swaps | Other Liabilities, Noncurrent
Fair values of derivative instruments in the consolidated balance sheet
Derivative Liabilities	$ 4,207	$ 5,022

XML

Basis of Presentation and Conventions Used in this Report (Details) (USD $)	3 Months Ended
	May 31, 2012 segment	Feb. 29, 2012
Basis of Presentation and Conventions Used in this Report
Common shares, par value (in dollars per share)	$ 0.10	$ 0.10
Number of segments	3

XML

Supplemental Balance Sheet Information (Tables)

3 Months Ended

May 31, 2012

Supplemental Balance Sheet Information

Schedule of property and equipment

	Estimated
	Useful Lives	May 31,			February 29,
	(Years)	2012			2012
Land	-	$	8,767		$	8,767
Building and improvements	3 - 40	66,953			66,580
Computer, furniture and other equipment	3 - 15	57,475			56,162
Tools, molds and other production equipment	1 - 10	30,165			25,617
Construction in progress	-	4,968			6,114
Property and equipment, gross		168,328			163,240
Less accumulated depreciation		(67,498		)	(62,550		)
Property and equipment, net		$	100,830		$	100,690

Summary of accrued expenses and other current liabilities

	May 31,		February 29,
	2012		2012
Accrued sales returns, discounts and allowances	$	27,885	$	29,481
Accrued warranty returns	23,313		26,665
Accrued compensation, benefits and payroll taxes	16,673		31,754
Accrued advertising	9,865		7,849
Accrued royalties	6,059		6,990
Accrued property, sales and other taxes	6,012		5,745
Accrued legal expenses and professional fees	5,482		5,364
Derivative liabilities	3,464		3,694
Other	14,698		14,090
Total accrued expenses and other current liabilities	$	113,451	$	131,632

Summary of other noncurrent liabilities

(in thousands)

	May 31,		February 29,
	2012		2012
Deferred compensation liability	$	4,648	$	4,478
Liability for uncertain tax positions	13,284		13,213
Derivative liabilities	4,207		5,022
Other liabilites	1,661		1,816
Total other liabilities, noncurrent	$	23,800	$	24,529

XML

Debt (Details 2) (USD $)	3 Months Ended
	May 31, 2012	Feb. 29, 2012
Long-term debt
Total long-term debt	$ 178,000,000	$ 178,000,000
Less current maturities of long-term debt	(3,000,000)	(3,000,000)
Long-term debt, excluding current maturities	175,000,000	175,000,000
Limit on additional debt borrowings	251,800,000
Fixed rate Senior Notes
Long-term debt
Fixed rate debt	103,000,000
Fixed rate Senior Notes | Fair Value, Level 2
Long-term debt
Fixed rate debt	104,430,000
7.24% unsecured senior note payable
Long-term debt
Face amount	15,000,000
Interest rate (as a percent)	7.24%
Interest rate (as a percent)	7.24%
Principal payments	3,000,000
Frequency of principal payment	Annual
Total long-term debt	3,000,000	3,000,000
3.90% unsecured senior notes payable
Long-term debt
Face amount	100,000,000
Interest rate (as a percent)	3.90%
Interest rate (as a percent)	3.90%
Principal payments	20,000,000
Frequency of principal payment	Annual
Total long-term debt	100,000,000	100,000,000
Unsecured floating interest rate 10 year Senior Notes
Long-term debt
Face amount	75,000,000
Interest rate (as a percent)	6.01%
Debt instrument term (in years)	10
Variable Rate Basis	three-month LIBOR
Basis spread on variable rate (as percent)	0.90%
Total long-term debt	$ 75,000,000	$ 75,000,000

XML

Comprehensive Income (Loss) (Details) (USD $)	May 31, 2012	Feb. 29, 2012
Unrealized holding losses on cash flow hedges, net of tax	$ (4,464,000)	$ (5,589,000)
Interest rate swaps
Unrealized holding losses on cash flow hedges, net of tax	(4,986,000)	(5,559,000)
Deferred tax benefits (liabilities) included in accumulated other comprehensive loss	2,680,000	2,990,000
Foreign currency contracts
Unrealized holding losses on cash flow hedges, net of tax	522,000	(30,000)
Deferred tax benefits (liabilities) included in accumulated other comprehensive loss	$ (280,000)	$ 20,000

XML

Financial Instruments and Risk Management (Details 4) (Cash flow hedges, USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	$ 866	$ (2,929)
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income	(900)	(1,670)
Gain/ (Loss) Recognized as Income	35	(63)
Currency contracts
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	910	(487)
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income	26	(144)
Gain/ (Loss) Recognized as Income	35	(63)
Gain/ (Loss) recorded in AOCI to be reclassified into income over the next year	380
Interest rate swaps
Pre-tax effect of derivative instruments
Gain/ (Loss) Recognized in OCI (effective portion)	(44)	(2,442)
Gain/ (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income	(926)	(1,526)
Gain/ (Loss) recorded in AOCI to be reclassified into income over the next year	$ (3,460)

XML

Commitments and Contingencies

3 Months Ended

May 31, 2012

Commitments and Contingencies

Commitments and Contingencies

Note 3 – Commitments and Contingencies

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

Notes (7), (9), (10), (11), and (14) provide additional information regarding certain of our significant long-term commitments and certain significant contingencies we have provided for in the accompanying consolidated condensed financial statements.

Our products are under warranty against defects in material and workmanship for periods ranging from two to five years. We estimate our warranty accrual using historical trends and believe that these trends are the most reliable method by which we can estimate our warranty liability.  The following table summarizes the activity in our warranty accrual for the periods covered in the accompanying consolidated condensed statements of income:

ACCRUAL FOR WARRANTY RETURNS

(in thousands)

	Three Months Ended May 31,
	2012			2011
Beginning balance	$	26,665		$	24,021
Additions to the accrual	6,874			7,110
Reductions of the accrual - payments and credits issued	(10,226		)	(6,762		)
Ending balance	$	23,313		$	24,369

XML

Fair Value (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	12 Months Ended
	May 31, 2012	Feb. 29, 2012
Note receivable
Fair value additional disclosures
Discount rate (as a percent)		6.95%
Long-term debt - fixed rate | Minimum
Fair value additional disclosures
Discount rate (as a percent)	0.29%	0.54%
Long-term debt - fixed rate | Maximum
Fair value additional disclosures
Discount rate (as a percent)	3.50%	3.54%
Recurring | Fair Values
Assets:
Note receivable		737
Total assets	1,813	1,538
Liabilities:
Total liabilities	187,101	188,166
Recurring | Fair Values | Interest rate swaps
Liabilities:
Derivative liabilities	7,671	8,553
Recurring | Fair Values | Foreign currency contracts
Assets:
Cash and cash equivalents	382
Liabilities:
Derivative liabilities		163
Recurring | Fair Values | Long-term debt - fixed rate
Liabilities:
Long-term debt	104,430	104,450
Recurring | Fair Values | Long-term debt - floating rate
Liabilities:
Long-term debt	75,000	75,000
Recurring | Fair Values | Money market accounts
Assets:
Cash and cash equivalents	1,431	801
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total assets	1,431	801
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market accounts
Assets:
Cash and cash equivalents	1,431	801
Recurring | Significant Other Observable Market Inputs (Level 2)
Assets:
Note receivable		737
Total assets	382	737
Liabilities:
Total liabilities	187,101	188,166
Recurring | Significant Other Observable Market Inputs (Level 2) | Interest rate swaps
Liabilities:
Derivative liabilities	7,671	8,553
Recurring | Significant Other Observable Market Inputs (Level 2) | Foreign currency contracts
Assets:
Cash and cash equivalents	382
Liabilities:
Derivative liabilities		163
Recurring | Significant Other Observable Market Inputs (Level 2) | Long-term debt - fixed rate
Liabilities:
Long-term debt	104,430	104,450
Recurring | Significant Other Observable Market Inputs (Level 2) | Long-term debt - floating rate
Liabilities:
Long-term debt	75,000	75,000

XML

Fair Value (Tables)

3 Months Ended

May 31, 2012

Fair Value

Schedule of fair value hierarchy of financial assets and liabilities carried at fair value and measured on a recurring basis

(in thousands)
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	May 31, 2012		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,431	$	1,431	$	-
Foreign currency contracts	382		-		382
Total assets	$	1,813	$	1,431	$	382
Liabilities:
Long-term debt - fixed rate (1)	$	104,430	$	-	$	104,430
Long-term debt - floating rate	75,000		-		75,000
Interest rate swap	7,671		-		7,671
Total liabilities	$	187,101	$	-	$	187,101
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	February 29, 2012		(Level 1)		(Level 2)
Assets:
Money market accounts	$	801	$	801	$	-
Note receivable (1)	737		-		737
Total assets	$	1,538	$	801	$	737
Liabilities:
Long-term debt - fixed rate (1)	$	104,450	$	-	$	104,450
Long-term debt - floating rate	75,000		-		75,000
Interest rate swap	8,553		-		8,553
Foreign currency contracts	163		-		163
Total liabilities	$	188,166	$	-	$	188,166

(1)Note receivable and debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

XML

Debt (Tables)

3 Months Ended

May 31, 2012

Debt

Summary of long-term debt

(dollars in thousands)
	Original
	Date	Interest		May 31,			February 29,
	Borrowed	Rates	Matures	2012			2012
$15 million unsecured Senior Note payable at a fixed interest rate of 7.24%. Interest payable quarterly. Annual principal payments of $3 million began in July 2008.	07/97	7.24%	07/12	$	3,000		$	3,000
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due at maturity. Notes can be prepaid without penalty. (1)	06/04	6.01%	06/14	75,000			75,000
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a “make whole” premium.	01/11	3.90%	01/18	100,000			100,000
Total long-term debt				178,000			178,000
Less current maturities of long-term debt				(3,000		)	(3,000		)
Long-term debt, excluding current maturities				$	175,000		$	175,000

(1)Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additional information regarding the swap is provided in Note (12) to these consolidated condensed financial statements.

XML

Financial Instruments and Risk Management (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Foreign Currency Risk
Net foreign exchange gains (losses), including the impact of currency hedges, in SG&A	$ (0.94)	$ (0.15)
Net foreign exchange gains (losses), including the impact of currency hedges, in income tax expense	$ 0.19	$ (0.04)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk
Percentage of net sales revenue in foreign currencies	17.00%	20.00%

XML

Financial Instruments and Risk Management (Tables)

3 Months Ended

May 31, 2012

Financial Instruments and Risk Management

Schedule of fair values of derivative instruments

(in thousands)

May 31, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	120	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	2/2013	£	5,750	262		-		-
Subtotal					382		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,464		4,207
Total fair value					$	382	$	3,464	$	4,207
February 29, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	-	$	163	$	-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,531		5,022
Total fair value					$	-	$	3,694	$	5,022

Schedule of pre-tax effect of derivative instruments

(in thousands)
	Three Months Ended May 31,
	Gain \ (Loss)						Gain \ (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain \ (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2012			2011			Location	2012			2011			Location	2012		2011
Currency contracts - ordinary and cash flow hedges	$	910		$	(487	)	SG&A	$	26		$	(144	)	SG&A	$	35	$	(63	)
Interest rate swaps - cash flow hedges	(44		)	(2,442		)	Interest expense	(926		)	(1,526		)		-		-
Total	$	866		$	(2,929	)		$	(900	)	$	(1,670	)		$	35	$	(63	)

(1) The amounts shown represent the ineffective portion of the change in fair value of a cash flow hedge.

XML

Repurchase of Helen of Troy Common Stock (Tables)

3 Months Ended

May 31, 2012

Repurchase of Helen of Troy Common Stock

Schedule of repurchase of common stock

	Three Months Ended May 31,
	2012		2011
Value of common stock received as exercise price of options
Number of shares	44,444		26,183
Aggregate market value of shares (in thousands)	$	1,476	$	837
Average price per share	$	33.20	$	31.98
Value of common stock received from director stock compensation activity
Number of shares	1,122		-
Aggregate market value of shares (in thousands)	$	37	$	-
Average price per share	$	32.88	$	-

XML

New Accounting Pronouncements

3 Months Ended

May 31, 2012

New Accounting Pronouncements

New Accounting Pronouncements

Note 2 – New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that we adopt according to the various timetables the FASB specifies.  Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.

XML

Share-Based Compensation Plans (Tables)

3 Months Ended

May 31, 2012

Share-Based Compensation Plans

Schedule of share-based payment expense

(in thousands, except per share data)

	Three Months Ended May 31,
	2012			2011
Stock options	$	547		$	466
Directors stock compensation	123			-
Performance based restricted stock awards and units	932			-
Share-based payment expense	1,602			466
Less income tax benefits	(265		)	(25		)
Share-based payment expense, net of income tax benefits	$	1,337		$	441
Earnings per share impact of share based payment expense:
Basic	$	0.04		$	0.01
Diluted	$	0.04		$	0.01

XML

Acquisitions (Details) (PUR, USD $)	1 Months Ended
	Dec. 31, 2011
Acquisitions
Percentage of stock acquired	100.00%
Net purchase price	$ 160,000,000
Assets
Supplier tooling advances	1,432,000
Goodwill	86,162,000
Total assets acquired	191,929,000
Liabilities
Less: Deferred tax liabilities recorded at acquisition	(31,929,000)
Net assets acquired	160,000,000
Fair value key assumptions
Discount rate (as a percent)	15.20%
Patent
Acquisitions
Expected weighted average lives of acquired finite-lived intangible assets (in years)	12.4
Assets
Finite-lived intangible assets	4,140,000
Patent | Minimum
Fair value key assumptions
Royalty rates (as a percent)	0.50%
Patent | Maximum
Fair value key assumptions
Royalty rates (as a percent)	1.00%
Customer list
Acquisitions
Expected weighted average lives of acquired finite-lived intangible assets (in years)	15.0
Assets
Finite-lived intangible assets	18,600,000
Fair value key assumptions
Customer attrition rates (as a percent)	5.00%
Trademark and technology licensing agreements
Acquisitions
Expected weighted average lives of acquired finite-lived intangible assets (in years)	5.2
Assets
Finite-lived intangible assets	14,900,000
Covenant not to compete
Acquisitions
Expected weighted average lives of acquired finite-lived intangible assets (in years)	2.0
Assets
Finite-lived intangible assets	200,000
Trademarks - indefinite
Assets
Indefinite-lived intangible assets	54,000,000
Fair value key assumptions
Royalty rates (as a percent)	7.00%
Tools, dies, molds and other production equipment
Assets
Property and equipment	$ 12,495,000

XML

Consolidated Condensed Balance Sheets (USD $) In Thousands, unless otherwise specified	May 31, 2012	Feb. 29, 2012
Assets, current:
Cash and cash equivalents	$ 20,880	$ 21,846
Receivables - principally trade, less allowances of $5,153 and $5,541	188,264	195,283
Inventory, net	259,989	246,142
Prepaid expenses and other current assets	8,093	7,645
Deferred tax assets, net	14,724	17,620
Total assets, current	491,950	488,536
Property and equipment, net of accumulated depreciation of $67,498 and $62,550	100,830	100,690
Goodwill	452,285	452,350
Other intangible assets, net of accumulated amortization of $57,800 and $52,268	371,709	377,150
Deferred tax assets, net	627	976
Other assets, net of accumulated amortization of $4,377 and $3,938	15,877	16,021
Total assets	1,433,278	1,435,723
Liabilities, current:
Revolving line of credit	158,000	171,100
Accounts payable, principally trade	72,911	69,845
Accrued expenses and other current liabilities	113,451	131,632
Income taxes payable	498	352
Deferred tax liabilities, net	887	2,960
Long-term debt, current maturities	3,000	3,000
Total liabilities, current	348,747	378,889
Long-term debt, excluding current maturities	175,000	175,000
Deferred tax liabilities, net	58,261	60,576
Other liabilities, noncurrent	23,800	24,529
Total liabilities	605,808	638,994
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued
Common stock, $0.10 par. Authorized 50,000,000 shares; 31,732,256 and 31,681,067 shares issued and outstanding	3,173	3,168
Additional paid in capital	157,615	151,006
Accumulated other comprehensive loss	(4,464)	(5,589)
Retained earnings	671,146	648,144
Total stockholders' equity	827,470	796,729
Total liabilities and stockholders' equity	$ 1,433,278	$ 1,435,723

XML

Financial Instruments and Risk Management (Details 2) (USD $) In Millions, unless otherwise specified	3 Months Ended
	May 31, 2012
2010 RCA
Financial instruments and risk management
Advances	$ 158.00
Fixed rate Senior Notes
Financial instruments and risk management
Senior Notes	103.00
Fixed rate Senior Notes | Minimum
Financial instruments and risk management
Fixed interest rate (as a percent)	3.90%
Fixed rate Senior Notes | Maximum
Financial instruments and risk management
Fixed interest rate (as a percent)	7.24%
Floating interest rate Senior Notes due June 2014
Financial instruments and risk management
Senior Notes	75.00
Effective fixed interest rate on debt (as a percent)	6.01%
Interest rate swaps
Financial instruments and risk management
Aggregate notional principal amount	$ 75.00
Derivative fixed interest rate (as a percent)	5.11%
Derivative variable rate (as a percent)	0.47%
Base rate, description	three-month LIBOR
Interest rate swaps | Floating interest rate Senior Notes due June 2014
Financial instruments and risk management
Effective fixed interest rate on debt (as a percent)	6.01%
Percentage of change in floating interest rate offset by swap	100.00%
Effectiveness percentage of swap	100.00%

XML

Consolidated Condensed Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Cash provided (used) by operating activities:
Net income	$ 23,472	$ 24,605
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	9,100	7,094
Provision for doubtful receivables	(168)	227
Share-based compensation	1,602	466
Gain on the sale of property and equipment	(4)	(24)
Realized and unrealized loss on investments		56
Deferred income taxes and tax credits	(1,804)	1,373
Changes in operating capital:
Receivables	7,187	(8,634)
Inventories	(13,742)	(11,004)
Prepaid expenses and other current assets	(675)	(2,862)
Other assets and liabilities, net	(779)	(543)
Accounts payable	3,066	4,224
Accrued expenses and other current liabilities	(18,206)	(11,002)
Accrued income taxes	(28)	447
Net cash provided by operating activities	9,021	4,423
Cash provided (used) by investing activities:
Capital and intangible asset expenditures	(3,368)	(2,036)
Proceeds from the sale of property and equipment	7	24
Proceeds from note receivable related to land sale	737
Proceeds from sale of investments		3,050
Net cash provided (used) by investing activities	(2,624)	1,038
Cash provided (used) by financing activities:
Proceeds from line of credit	59,950	142,700
Repayment of line of credit	(73,050)	(160,500)
Payments of financing costs	(28)	(24)
Proceeds from exercise of stock options and employee stock purchases, including tax benefits	5,537	1,182
Directors' stock repurchased	(37)
Share-based compensation tax benefit	265	25
Net cash used by financing activities	(7,363)	(16,617)
Net decrease in cash and cash equivalents	(966)	(11,156)
Cash and cash equivalents, beginning balance	21,846	27,193
Cash and cash equivalents, ending balance	$ 20,880	$ 16,037

XML

Earnings per Share (Details) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Weighted average diluted securities
Weighted average shares outstanding, basic	31,699	30,857
Incremental shares of common stock attributable to share-based payment arrangements	141	803
Weighted average shares outstanding, diluted	31,840	31,660
Dilutive securities, as a result of in-the-money options (in shares)	423	2,338
Antidilutive securities, as a result of out-of-the-money options (in shares)	625	407

XML

Earnings per Share (Tables)

3 Months Ended

May 31, 2012

Earnings per Share

Schedule of components of basic and diluted shares

	Three Months Ended May 31,
	2012	2011
Weighted average shares outstanding, basic	31,699	30,857
Incremental shares of common stock attributable to share-based payment arrangements	141	803
Weighted average shares outstanding, diluted	31,840	31,660
Dilutive securities, as a result of in-the-money options	423	2,338
Antidilutive securities, as a result of out-of-the-money options	625	407

XML

Segment Information (Details) (USD $)	3 Months Ended
	May 31, 2012	May 31, 2011
Segment information
Sales revenue, net	$ 300,211,000	$ 271,467,000
Operating income (loss)	31,148,000	30,654,000
Capital and intangible asset expenditures	3,368,000	2,036,000
Depreciation and amortization	9,100,000	7,094,000
Personal Care
Segment information
Sales revenue, net	117,552,000	122,718,000
Operating income (loss)	11,880,000	19,852,000
Capital and intangible asset expenditures	2,255,000	897,000
Depreciation and amortization	3,267,000	2,661,000
Housewares
Segment information
Sales revenue, net	60,249,000	52,946,000
Operating income (loss)	11,277,000	10,865,000
Capital and intangible asset expenditures	191,000	580,000
Depreciation and amortization	1,298,000	1,441,000
Healthcare/Home Environment
Segment information
Sales revenue, net	122,410,000	95,803,000
Operating income (loss)	7,991,000	(63,000)
Capital and intangible asset expenditures	922,000	559,000
Depreciation and amortization	4,535,000	2,992,000
Overhead allocation	$ 4,120,000	$ 1,500,000

XML

Comprehensive Income (Loss) (Tables)

3 Months Ended

May 31, 2012

Comprehensive Income (Loss)

Schedule of components of accumulated other comprehensive loss

(in thousands)

	May 31,			February 29,
	2012			2012
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1)	$	(4,986	)	$	(5,559	)
Unrealized holding gains (losses) on cash flow hedges - foreign currency, net of tax (2)	522			(30		)
Total accumulated other comprehensive loss	$	(4,464	)	$	(5,589	)

(1) Includes net deferred tax benefits of $2.68 and $2.99 million at May 31, 2012 and February 29, 2012, respectively.

(2) Includes net deferred tax benefits (liabilities) of ($0.28) and $0.02 million at May 31, 2012 and February 29, 2012, respectively.

XML

Basis of Presentation and Conventions Used in this Report

3 Months Ended

May 31, 2012

Basis of Presentation and Conventions Used in this Report

Basis of Presentation and Conventions Used in this Report

Note 1 - Basis of Presentation and Conventions Used in this Report

The accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of May 31, 2012 and February 29, 2012, and the results of our consolidated operations for the three month periods ended May 31, 2012 and 2011. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 29, 2012, and our other reports on file with the Securities and Exchange Commission (“SEC”).

In this report and the accompanying consolidated condensed financial statements and notes, unless the context suggests otherwise or otherwise indicated, references to “the Company,” “our Company,” “Helen of Troy,” “we,” “us,” or “our” refer to Helen of Troy Limited and its subsidiaries, and amounts are expressed in thousands of U.S. Dollars.  We refer to the Company’s common shares, par value $0.10 per share, as “common stock.” References to “Kaz” refer to the operations of Kaz, Inc. and its subsidiaries.  References to “PUR” refer to the PUR brand of water filtration products that we acquired, along with certain other assets and liabilities, from The Procter & Gamble Company and certain of its affiliates on December 30, 2011. Kaz and PUR comprise a segment within the Company referred to as the Healthcare / Home Environment segment.  References to “OXO” refer to the operations of OXO International and certain of its affiliated subsidiaries that comprise our Housewares segment. Product and service names mentioned in this report are used for identification purposes only and may be protected by trademarks, trade names, services marks, and/or other intellectual property rights of the Company and/or other parties in the United States and/or other jurisdictions. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their owners.  References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to U.S. generally accepted accounting principles. References to “ASC” refer to the codification of U.S. GAAP in the Accounting Standards Codification issued by the FASB.

We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. We have three segments: Personal Care, Housewares and Healthcare / Home Environment. Our Personal Care segment’s products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid, solid- and powder-based personal care and grooming products. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment focuses on health care devices such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances such as air purifiers, portable heaters, fans, and bug zappers. All three segments sell their products primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, and specialty stores. In addition, the Personal Care segment sells extensively through beauty supply retailers and wholesalers, and the Healthcare / Home Environment segment sells certain of its product lines through medical distributors and other products through home improvement stores. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.

Our consolidated condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates.  We have reclassified, combined or separately disclosed certain amounts in the prior period’s consolidated condensed financial statements and accompanying footnotes to conform to the current period’s presentation.

XML

Consolidated Condensed Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	May 31, 2012	Feb. 29, 2012
Consolidated Condensed Balance Sheets
Receivables - principally trade, allowances (in dollars)	$ 5,153	$ 5,541
Property and equipment, accumulated depreciation (in dollars)	67,498	62,550
Other intangible assets, accumulated amortization (in dollars)	57,800	52,268
Other assets, accumulated amortization (in dollars)	$ 4,377	$ 3,938
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1.00	$ 1.00
Cumulative preferred stock, non-voting, Authorized shares	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, Authorized shares	50,000,000	50,000,000
Common stock, shares issued	31,732,256	31,681,067
Common stock, shares outstanding	31,732,256	31,681,067

XML

Fair Value

3 Months Ended

May 31, 2012

Fair Value

Fair Value

Note 11 – Fair Value

The fair value hierarchy of our financial assets and liabilities carried at fair value and measured on a recurring basis is as follows:

FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES

(in thousands)
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	May 31, 2012		(Level 1)		(Level 2)
Assets:
Money market accounts	$	1,431	$	1,431	$	-
Foreign currency contracts	382		-		382
Total assets	$	1,813	$	1,431	$	382
Liabilities:
Long-term debt - fixed rate (1)	$	104,430	$	-	$	104,430
Long-term debt - floating rate	75,000		-		75,000
Interest rate swap	7,671		-		7,671
Total liabilities	$	187,101	$	-	$	187,101
			Quoted Prices in		Significant Other
			Active Markets		Observable
	Fair Values at		for Identical Assets		Market Inputs
Description	February 29, 2012		(Level 1)		(Level 2)
Assets:
Money market accounts	$	801	$	801	$	-
Note receivable (1)	737		-		737
Total assets	$	1,538	$	801	$	737
Liabilities:
Long-term debt - fixed rate (1)	$	104,450	$	-	$	104,450
Long-term debt - floating rate	75,000		-		75,000
Interest rate swap	8,553		-		8,553
Foreign currency contracts	163		-		163
Total liabilities	$	188,166	$	-	$	188,166

(1)Note receivable and debt values are reported at estimated fair value in these tables, but are recorded in the accompanying consolidated condensed balance sheets at the undiscounted value of remaining principal payments due.

The carrying amounts of cash and cash equivalents, receivables, accounts payable, accrued expenses, and income taxes payable approximate fair value because of the short maturity of these items.

Money market accounts are included in cash and cash equivalents in the accompanying consolidated condensed balance sheets and are classified as Level 1 assets.

We classify our note receivable, fixed and floating rate debt as Level 2 liabilities because the estimation of the fair market value of these financial assets requires the use of a discount rate based upon current market rates of interest for debt with comparable remaining terms. Such comparable rates are significant other observable market inputs. The fair market value of the note receivable was computed using a discounted cash flow analysis and a discount rate of 6.95 percent at February 29, 2012. The fair market value of the fixed rate debt was computed using a discounted cash flow analysis and discount rates, ranging from 0.29 to 3.50 percent at May 31, 2012 and 0.54 to 3.54 percent at February 29, 2012, depending on the term of the loan. All other long-term debt has floating interest rates, and its book value approximates its fair value as of the reporting date.

We use derivatives for hedging purposes and our derivatives are primarily foreign currency contracts and an interest rate swap. We determine the fair value of our derivative instruments based on Level 2 inputs in the fair value hierarchy.

The Company’s other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 assets. These assets are measured at fair value on a non-recurring basis as part of the Company’s impairment assessments and as circumstances require.

XML

Document and Entity Information	3 Months Ended
	May 31, 2012	Jul. 02, 2012
Document and Entity Information
Entity Registrant Name	HELEN OF TROY LTD
Entity Central Index Key	0000916789
Document Type	10-Q
Document Period End Date	May 31, 2012
Amendment Flag	false
Current Fiscal Year End Date	--02-28
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		31,736,452
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1

XML

Financial Instruments and Risk Management

3 Months Ended

May 31, 2012

Financial Instruments and Risk Management

Financial Instruments and Risk Management

Note 12 – Financial Instruments and Risk Management

Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three month periods ended May 31, 2012 and 2011, approximately 17 and 20 percent, respectively, of our net sales revenue was in foreign currencies.  These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars, Japanese Yen, Australian Dollars, Chilean Pesos, Peruvian Soles, and Venezuelan Bolivares Fuertes. We make most of our inventory purchases from the Far East and use the U.S. Dollar for such purchases.  In our consolidated condensed statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities, are recognized in their respective income tax lines, and all other foreign exchange gains and losses from remeasurement are recognized in SG&A.  For the three month periods ended May 31, 2012 and 2011, we recorded net foreign exchange gains (losses), including the impact of currency hedges, of ($0.94) and ($0.15) million, respectively, in SG&A and $0.19 and ($0.04) million, respectively, in income tax expense.

We have historically hedged against certain foreign currency exchange rate risk by using a series of forward contracts designated as cash flow hedges to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar.  We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes.

Interest Rate Risk – Interest on our outstanding debt as of May 31, 2012 is both floating and fixed.  Fixed rates are in place on $103.00 million of Senior Notes at rates ranging from 3.90 to 7.24 percent and floating rates are in place on $158.00 million in advances against our 2010 RCA and $75.00 million of Senior Notes due June 2014.  If short-term interest rates increase, we will incur higher interest rates on any outstanding balances under the 2010 RCA. The floating rate Senior Notes due June 2014 reset as described in Note 10, and have been effectively converted to fixed rate debt using an interest rate swap (the “swap”), as described below.

We manage our floating rate debt using an interest rate swap.  As of May 31, 2012, the swap converted an aggregate notional principal amount of $75.00 million from floating interest rate payments under our Senior Notes due June 2014 to fixed interest rate payments at 6.01 percent.  In the swap transaction, we maintain contracts to pay fixed rates of interest on an aggregate notional principal amount of $75.00 million at a rate of 5.11 percent on our Senior Notes due June 2014, while simultaneously receiving floating rate interest payments set at 0.47 percent as of May 31, 2012 on the same notional amounts.  The fixed rate side of the swap will not change over its life.  The floating rate payments are reset quarterly based on three-month LIBOR.  The resets are concurrent with the interest payments made on the underlying debt. Changes in the spread between the fixed rate payment side of the swap and the floating rate receipt side of the swap offset 100 percent of the change in any period of the underlying debt’s floating rate payments.  The swap is used to reduce our risk of increased interest costs; however, when interest rates drop significantly below the swap rate, we lose the benefit that our floating rate debt would provide, if not managed with a swap. The swap is considered 100 percent effective.

The fair values of our various derivative instruments are as follows:

FAIR VALUES OF DERIVATIVE INSTRUMENTS

(in thousands)

May 31, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	120	$	-	$	-
Foreign currency contracts - sell Pounds	Cash flow	2/2013	£	5,750	262		-		-
Subtotal					382		-		-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,464		4,207
Total fair value					$	382	$	3,464	$	4,207
February 29, 2012
					Prepaid		Accrued
					Expenses		Expenses
		Final			and Other		and Other		Other
		Settlement	Notional		Current		Current		Liabilities,
Designated as hedging instruments	Hedge Type	Date	Amount		Assets		Liabilities		Noncurrent
Foreign currency contracts - sell Canadian	Cash flow	12/2012	$	7,000	$	-	$	163	$	-
Interest rate swap	Cash flow	6/2014	$	75,000	-		3,531		5,022
Total fair value					$	-	$	3,694	$	5,022

The pre-tax effect of derivative instruments for the periods covered in the accompanying consolidated condensed financial statements are as follows:

PRE-TAX EFFECT OF DERIVATIVE INSTRUMENTS
(in thousands)
	Three Months Ended May 31,
	Gain \ (Loss)						Gain \ (Loss) Reclassified
	Recognized in OCI						from Accumulated Other							Gain \ (Loss) Recognized
	(effective portion)						Comprehensive Loss into Income							as Income (1)
	2012			2011			Location	2012			2011			Location	2012		2011
Currency contracts - ordinary and cash flow hedges	$	910		$	(487	)	SG&A	$	26		$	(144	)	SG&A	$	35	$	(63	)
Interest rate swaps - cash flow hedges	(44		)	(2,442		)	Interest expense	(926		)	(1,526		)		-		-
Total	$	866		$	(2,929	)		$	(900	)	$	(1,670	)		$	35	$	(63	)

(1) The amounts shown represent the ineffective portion of the change in fair value of a cash flow hedge.

We expect gains of $0.38 million associated with foreign currency contracts and losses of $3.46 million associated with our interest rate swap, currently reported in accumulated other comprehensive loss, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle.

Counterparty Credit Risk - Financial instruments, including foreign currency contracts and interest rate swaps, expose us to counterparty credit risk for nonperformance.  We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.  Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote.

XML

Consolidated Condensed Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Sales revenue, net	$ 300,211	$ 271,467
Cost of goods sold	179,063	161,554
Gross profit	121,148	109,913
Selling, general and administrative expense	90,000	79,259
Operating income	31,148	30,654
Nonoperating income (expense), net	23	143
Interest expense	(3,312)	(3,429)
Income before income taxes	27,859	27,368
Income tax expense:
Current	5,901	1,390
Deferred	(1,514)	1,373
Net income	$ 23,472	$ 24,605
Earnings per share:
Basic (in dollars per share)	$ 0.74	$ 0.80
Diluted (in dollars per share)	$ 0.74	$ 0.78
Weighted average shares of common stock used in computing net earnings per share:
Basic (in shares)	31,699	30,857
Diluted (in shares)	31,840	31,660

XML

Comprehensive Income (Loss)

3 Months Ended

May 31, 2012

Comprehensive Income (Loss)

Comprehensive Income (Loss)

Note 6 – Comprehensive Income (Loss)

The components of accumulated other comprehensive loss, net of tax, are as follows:

COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS

(in thousands)

	May 31,			February 29,
	2012			2012
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1)	$	(4,986	)	$	(5,559	)
Unrealized holding gains (losses) on cash flow hedges - foreign currency, net of tax (2)	522			(30		)
Total accumulated other comprehensive loss	$	(4,464	)	$	(5,589	)

(1) Includes net deferred tax benefits of $2.68 and $2.99 million at May 31, 2012 and February 29, 2012, respectively.

(2) Includes net deferred tax benefits (liabilities) of ($0.28) and $0.02 million at May 31, 2012 and February 29, 2012, respectively.

XML

Segment Information

3 Months Ended

May 31, 2012

Segment Information

Segment Information

Note 5 – Segment Information

The following tables contain segment information for the periods covered in the accompanying consolidated condensed statements of income:

THREE MONTHS ENDED MAY 31, 2012 AND 2011

(in thousands)

	Personal				Healthcare / Home
May 31, 2012	Care		Housewares		Environment			Total
Sales revenue, net	$	117,552	$	60,249	$	122,410		$	300,211
Operating income	11,880		11,277		7,991			31,148
Capital and intangible asset expenditures	2,255		191		922			3,368
Depreciation and amortization	3,267		1,298		4,535			9,100
	Personal				Healthcare / Home
May 31, 2011	Care		Housewares		Environment			Total
Sales revenue, net	$	122,718	$	52,946	$	95,803		$	271,467
Operating income (loss)	19,852		10,865		(63		)	30,654
Capital and intangible asset expenditures	897		580		559			2,036
Depreciation and amortization	2,661		1,441		2,992			7,094

We compute operating income for each segment based on net sales revenue, less cost of goods sold, selling, general and administrative expense (“SG&A”), and any impairment charges associated with the segment. SG&A used to compute each segment’s operating income is directly associated with the segment, plus overhead expenses allocable to the segment.  We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facilities square footage.  In fiscal 2013, we began making certain additional cost allocations to the Healthcare / Home Environment segment that were not made in fiscal 2012.  These allocations are costs of corporate and operating functions that are shared by our segments.   We made this change because we now have a complete fiscal year’s operating experience with the Healthcare / Home Environment segment.  In the past year we have integrated certain of the segment’s corporate and operating functions that were redundant. For the three month period ended May 31, 2012, the allocation totaled $4.12 million compared to $1.50 million for the same period last year.  We do not allocate nonoperating income and expense, interest or income taxes to operating segments.

XML

Segment Information (Tables)

3 Months Ended

May 31, 2012

Segment Information

Schedule of segment information

(in thousands)

	Personal				Healthcare / Home
May 31, 2012	Care		Housewares		Environment			Total
Sales revenue, net	$	117,552	$	60,249	$	122,410		$	300,211
Operating income	11,880		11,277		7,991			31,148
Capital and intangible asset expenditures	2,255		191		922			3,368
Depreciation and amortization	3,267		1,298		4,535			9,100
	Personal				Healthcare / Home
May 31, 2011	Care		Housewares		Environment			Total
Sales revenue, net	$	122,718	$	52,946	$	95,803		$	271,467
Operating income (loss)	19,852		10,865		(63		)	30,654
Capital and intangible asset expenditures	897		580		559			2,036
Depreciation and amortization	2,661		1,441		2,992			7,094

XML

Repurchase of Helen of Troy Common Stock

3 Months Ended

May 31, 2012

Repurchase of Helen of Troy Common Stock

Repurchase of Helen of Troy Common Stock

Note 13 – Repurchase of Helen of Troy Common Stock

As of May 31, 2012, we are authorized by our Board of Directors to purchase up to 3,022,788 shares of common stock in the open market or through private transactions.  Our current equity compensation plans include provisions that allow for the “cashless exercise” of stock options by all plan participants. In a cashless exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. Cashless exercises are accounted for by the Company as a purchase and retirement of shares.

For the periods covered in the accompanying consolidated condensed financial statements, there was no open market repurchase activity, however common stock option exercise and director stock compensation activity resulted in the following share repurchases:

SHARE REPURCHASES

	Three Months Ended May 31,
	2012		2011
Value of common stock received as exercise price of options
Number of shares	44,444		26,183
Aggregate market value of shares (in thousands)	$	1,476	$	837
Average price per share	$	33.20	$	31.98
Value of common stock received from director stock compensation activity
Number of shares	1,122		-
Aggregate market value of shares (in thousands)	$	37	$	-
Average price per share	$	32.88	$	-

XML

Acquisitions

3 Months Ended

May 31, 2012

Acquisitions

Acquisitions

NOTE 9 - Acquisitions

PUR Acquisition - On December 30, 2011, we completed an asset and stock purchase transaction in which we acquired 100 percent of the stock of PUR Water Purification Products, Inc., and certain other assets and liabilities from The Procter & Gamble Company and certain of its affiliates (“P&G”) for a net cash purchase price of $160 million, subject to future adjustments.  The acquisition was funded entirely with short-term debt.  Significant assets acquired include manufacturing equipment, trademarks, customer lists, distribution rights, patents, and the goodwill of the PUR water filtration business.  PUR’s product line includes faucet mount water filtration systems and filters, pitcher systems and filters, and refrigerator filters.  We are operating the PUR business in our Healthcare / Home Environment segment and market its products primarily into retail trade channels in the U.S.  Goodwill arising from the acquisition consists largely of the distribution network, marketing synergies and economies of scale that are anticipated from the addition of the new product line.

In connection with this acquisition, we entered into transitional services and supply agreements whereby P&G or one or more of its affiliates will provide certain short-term services for, and supply certain products to, the Company in exchange for specified fees. When we finish using certain of these services in the second quarter of fiscal 2013, we will acquire any remaining PUR inventory on-hand from P&G.

We accounted for the acquisition as the purchase of a business and recorded the excess purchase price as goodwill. None of the goodwill recognized is expected to be deductible for income tax purposes. We completed our preliminary estimate of the economic lives of all the assets acquired and a preliminary allocation of the initial purchase price. We assigned the acquired trademarks indefinite economic lives and are amortizing the customer list,  patents, trademarks and technology license agreements, and covenant not to compete over expected weighted average lives of approximately 15.0,  12.4,  5.2 and 2.0  years, respectively.  For the customer list, we used historical attrition rates to assign an expected life.  For patent rights, we used the underlying non-renewable term of a royalty-free license we acquired for the use of patented designs in certain PUR products. The trademarks acquired have indefinite lives that are not subject to amortization.

The following schedule presents the acquisition date fair value of the net assets of PUR:

PUR - NET ASSETS ACQUIRED ON DECEMBER 30, 2011

(in thousands)
Supplier tooling advances	$	1,432
Tools, dies, molds and other production equipment	12,495
Goodwill	86,162
Trademarks	54,000
Trademark and technology licensing agreements	14,900
Patents	4,140
Customer list	18,600
Covenant not to compete	200
Total assets acquired	191,929
Less: Deferred tax liabilities recorded at acquisition	(31,929		)
Net assets acquired	$	160,000

We estimated the fair values of the PUR assets acquired by applying income and market approaches. The fair value measurement of the intangible assets is based on significant inputs that are not observable in the market and, therefore, represent Level 3 measurements.  Key assumptions included various discount rates based upon a 15.20 percent weighted average cost of capital, a royalty rate of 7.0 percent used to determine the trademark fair value, royalty rates of 0.50 to 1.00 percent used to determine patent estate values, and customer attrition rates of 5.00 percent per year used to determine customer list value.

XML

Supplemental Balance Sheet Information

3 Months Ended

May 31, 2012

Supplemental Balance Sheet Information

Supplemental Balance Sheet Information

Note 7 – Supplemental Balance Sheet Information

PROPERTY AND EQUIPMENT

(in thousands)

	Estimated
	Useful Lives	May 31,			February 29,
	(Years)	2012			2012
Land	-	$	8,767		$	8,767
Building and improvements	3 - 40	66,953			66,580
Computer, furniture and other equipment	3 - 15	57,475			56,162
Tools, molds and other production equipment	1 - 10	30,165			25,617
Construction in progress	-	4,968			6,114
Property and equipment, gross		168,328			163,240
Less accumulated depreciation		(67,498		)	(62,550		)
Property and equipment, net		$	100,830		$	100,690

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

(in thousands)

	May 31,		February 29,
	2012		2012
Accrued sales returns, discounts and allowances	$	27,885	$	29,481
Accrued warranty returns	23,313		26,665
Accrued compensation, benefits and payroll taxes	16,673		31,754
Accrued advertising	9,865		7,849
Accrued royalties	6,059		6,990
Accrued property, sales and other taxes	6,012		5,745
Accrued legal expenses and professional fees	5,482		5,364
Derivative liabilities	3,464		3,694
Other	14,698		14,090
Total accrued expenses and other current liabilities	$	113,451	$	131,632

OTHER LIABILITIES, NONCURRENT

(in thousands)

	May 31,		February 29,
	2012		2012
Deferred compensation liability	$	4,648	$	4,478
Liability for uncertain tax positions	13,284		13,213
Derivative liabilities	4,207		5,022
Other liabilites	1,661		1,816
Total other liabilities, noncurrent	$	23,800	$	24,529

XML

Goodwill and Intangible Assets

3 Months Ended

May 31, 2012

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Note 8 – Goodwill and Intangible Assets

Annual Impairment Testing in the First Quarter of Fiscal 2013 and 2012 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal 2013 and 2012.   As a result, we concluded no impairment charges were required during either period.  For both periods, the estimated fair value of the indefinite-lived trademarks and licenses, reporting unit net assets, and the Company’s estimated enterprise value exceeded their respective carrying values as of the date of the evaluation.

A summary of the carrying amounts and associated accumulated amortization for all intangible assets by operating segment follows:

GOODWILL AND INTANGIBLE ASSETS

(in thousands)

	May 31, 2012										February 29, 2012
	Gross		Cumulative								Gross		Cumulative
	Carrying		Goodwill			Accumulated			Net Book		Carrying		Goodwill			Accumulated			Net Book
Description	Amount		Impairments			Amortization			Value		Amount		Impairments			Amortization			Value
Personal Care:
Goodwill	$	81,842	$	(46,490	)	$	-		$	35,352	$	81,842	$	(46,490	)	$	-		$	35,352
Trademarks - indefinite	75,303		-			-			75,303		75,303		-			-			75,303
Trademarks - finite	150		-			(68		)	82		150		-			(67		)	83
Licenses - indefinite	10,300		-			-			10,300		10,300		-			-			10,300
Licenses - finite	19,564		-			(16,097		)	3,467		19,564		-			(15,967		)	3,597
Other intangibles - finite	49,437		-			(16,505		)	32,932		49,437		-			(15,012		)	34,425
Total Personal Care	236,596		(46,490		)	(32,670		)	157,436		236,596		(46,490		)	(31,046		)	159,060
Housewares:
Goodwill	166,131		-			-			166,131		166,131		-			-			166,131
Trademarks - indefinite	75,200		-			-			75,200		75,200		-			-			75,200
Other intangibles - finite	15,765		-			(9,289		)	6,476		15,774		-			(9,000		)	6,774
Total Housewares	257,096		-			(9,289		)	247,807		257,105		-			(9,000		)	248,105
Healthcare / Home Environment:
Goodwill	250,802		-			-			250,802		250,867		-			-			250,867
Trademarks - indefinite	54,000		-			-			54,000		54,000		-			-			54,000
Licenses - finite	15,300		-			(1,234		)	14,066		14,900		-			(481		)	14,419
Other Intangibles - finite	114,490		-			(14,607		)	99,883		114,790		-			(11,741		)	103,049
Total Healthcare / Home Environment	434,592		-			(15,841		)	418,751		434,557		-			(12,222		)	422,335
Total	$	928,284	$	(46,490	)	$	(57,800	)	$	823,994	$	928,258	$	(46,490	)	$	(52,268	)	$	829,500

The following table summarizes the amortization expense attributable to intangible assets for the periods covered in the accompanying consolidated condensed statements of income, as well as our estimated amortization expense for the fiscal years 2013 through 2018.

AMORTIZATION OF INTANGIBLE ASSETS
(in thousands)
Aggregate Amortization Expense
For the three months ended
May 31, 2012	$	5,636
May 31, 2011	$	4,557

Estimated Amortization Expense
For the fiscal years ended
February 2013	$	22,190
February 2014	$	21,509
February 2015	$	20,945
February 2016	$	20,761
February 2017	$	20,423
February 2018	$	16,599

XML

Debt

3 Months Ended

May 31, 2012

Debt

Debt

Note 10 – Debt

Revolving Line of Credit - We have a Credit Agreement (the “2010 RCA”) with Bank of America, N.A. that provides for an unsecured total revolving commitment of up to $250.00 million. The commitment under the 2010 RCA terminates on December 30, 2015.  Borrowings accrue interest under one of two alternative methods as described in the 2010 RCA.  We also incur loan commitment fees and letter of credit fees under the 2010 RCA.  Outstanding letters of credit reduce the borrowing availability under the 2010 RCA on a dollar-for-dollar basis.  As of May 31, 2012, the outstanding revolving loan principal balance was $158.00 million and there were $0.35 million of open letters of credit outstanding against the 2010 RCA. For the three months ended May 31, 2012 and May 31, 2011, borrowings under the 2010 RCA incurred interest charges at rates ranging from 1.61 to 4.00 percent and 1.95 to 4.00 percent, respectively. As of May 31, 2012, the amount available for borrowings under the 2010 RCA was $91.65 million.

Long-Term Debt – A summary of our long-term debt is as follows:

LONG-TERM DEBT

(dollars in thousands)
	Original
	Date	Interest		May 31,			February 29,
	Borrowed	Rates	Matures	2012			2012
$15 million unsecured Senior Note payable at a fixed interest rate of 7.24%. Interest payable quarterly. Annual principal payments of $3 million began in July 2008.	07/97	7.24%	07/12	$	3,000		$	3,000
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due at maturity. Notes can be prepaid without penalty. (1)	06/04	6.01%	06/14	75,000			75,000
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a “make whole” premium.	01/11	3.90%	01/18	100,000			100,000
Total long-term debt				178,000			178,000
Less current maturities of long-term debt				(3,000		)	(3,000		)
Long-term debt, excluding current maturities				$	175,000		$	175,000

(1)Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additional information regarding the swap is provided in Note (12) to these consolidated condensed financial statements.

The fair market value of the fixed rate debt at May 31, 2012 computed using a discounted cash flow analysis was $104.43 million compared to the $103.00 million book value and represents a Level 2 liability. All other long-term debt has floating interest rates, and its book value approximates its fair value at May 31, 2012.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms is defined in the various agreements).  Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends.

As of May 31, 2012, our debt agreements effectively limited our ability to incur more than $251.80 million of additional debt from all sources, including draws on the 2010 RCA. As of May 31, 2012, we were in compliance with the terms of all of our debt agreements.

XML

Commitments and Contingencies (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012 Y	May 31, 2011
Warranties
Product warranty period, low end of range (in years)	2
Product warranty period, high end of range (in years)	5
Accrual for warranty returns
Beginning balance	$ 26,665	$ 24,021
Additions to accrual	6,874	7,110
Reductions of the accrual - payments and credits issued	(10,226)	(6,762)
Ending balance	$ 23,313	$ 24,369

XML

Commitments and Contingencies (Tables)

3 Months Ended

May 31, 2012

Commitments and Contingencies

Schedule of accrual for warranty returns

(in thousands)

	Three Months Ended May 31,
	2012			2011
Beginning balance	$	26,665		$	24,021
Additions to the accrual	6,874			7,110
Reductions of the accrual - payments and credits issued	(10,226		)	(6,762		)
Ending balance	$	23,313		$	24,369

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

May 31, 2012

Goodwill and Intangible Assets

Schedule of changes in goodwill and intangible assets by operating segment

(in thousands)

	May 31, 2012										February 29, 2012
	Gross		Cumulative								Gross		Cumulative
	Carrying		Goodwill			Accumulated			Net Book		Carrying		Goodwill			Accumulated			Net Book
Description	Amount		Impairments			Amortization			Value		Amount		Impairments			Amortization			Value
Personal Care:
Goodwill	$	81,842	$	(46,490	)	$	-		$	35,352	$	81,842	$	(46,490	)	$	-		$	35,352
Trademarks - indefinite	75,303		-			-			75,303		75,303		-			-			75,303
Trademarks - finite	150		-			(68		)	82		150		-			(67		)	83
Licenses - indefinite	10,300		-			-			10,300		10,300		-			-			10,300
Licenses - finite	19,564		-			(16,097		)	3,467		19,564		-			(15,967		)	3,597
Other intangibles - finite	49,437		-			(16,505		)	32,932		49,437		-			(15,012		)	34,425
Total Personal Care	236,596		(46,490		)	(32,670		)	157,436		236,596		(46,490		)	(31,046		)	159,060
Housewares:
Goodwill	166,131		-			-			166,131		166,131		-			-			166,131
Trademarks - indefinite	75,200		-			-			75,200		75,200		-			-			75,200
Other intangibles - finite	15,765		-			(9,289		)	6,476		15,774		-			(9,000		)	6,774
Total Housewares	257,096		-			(9,289		)	247,807		257,105		-			(9,000		)	248,105
Healthcare / Home Environment:
Goodwill	250,802		-			-			250,802		250,867		-			-			250,867
Trademarks - indefinite	54,000		-			-			54,000		54,000		-			-			54,000
Licenses - finite	15,300		-			(1,234		)	14,066		14,900		-			(481		)	14,419
Other Intangibles - finite	114,490		-			(14,607		)	99,883		114,790		-			(11,741		)	103,049
Total Healthcare / Home Environment	434,592		-			(15,841		)	418,751		434,557		-			(12,222		)	422,335
Total	$	928,284	$	(46,490	)	$	(57,800	)	$	823,994	$	928,258	$	(46,490	)	$	(52,268	)	$	829,500

Schedule of aggregate amortization expense of intangible assets

(in thousands)
Aggregate Amortization Expense
For the three months ended
May 31, 2012	$	5,636
May 31, 2011	$	4,557

Schedule of estimated amortization expense of intangible assets

For the fiscal years ended
February 2013	$	22,190
February 2014	$	21,509
February 2015	$	20,945
February 2016	$	20,761
February 2017	$	20,423
February 2018	$	16,599

XML

Share-Based Compensation Plans (Details) (USD $)	3 Months Ended						1 Months Ended	3 Months Ended	1 Months Ended	3 Months Ended	1 Months Ended
	May 31, 2012 plan	May 31, 2011	May 31, 2012 Stock options	May 31, 2011 Stock options	May 31, 2012 Stock options Minimum Y	May 31, 2012 Stock options Maximum Y	Mar. 31, 2012 Restricted stock Board members	May 31, 2012 Restricted stock Board members	Mar. 31, 2012 RSUs Performance based Chief Executive Officer and President	May 31, 2012 RSUs Performance based Chief Executive Officer and President	Mar. 31, 2012 RSUs Performance based - fiscal 2013 target Chief Executive Officer and President Maximum	Mar. 31, 2012 RSUs Performance based - fiscal 2014 target Chief Executive Officer and President Maximum	Mar. 31, 2012 RSUs Performance based - fiscal 2015 target Chief Executive Officer and President Y	Mar. 31, 2012 RSUs Performance based - fiscal 2015 target Chief Executive Officer and President Maximum
Share-Based Compensation Plans
Number of expired share-based compensation plans	2
Number of active share-based compensation plans	3
Share-based compensation plans
Granted in period			301,000
Exercise prices of stock units granted (in dollars per share)					$ 32.52	$ 34.72
Estimated grant date fair value (in dollars per share)					$ 13.16	$ 14.57
Term of award (in years)					P4Y	P5Y
Expected life					4.05	4.35
Risk free interest rates used (as a percent)					0.61%	0.86%
Expected dividend rate (as a percent)					0.00%	0.00%
Expected volatility rates used (as a percent)					50.95%	52.48%
Granted in period (in shares)							3,750		700,000		100,000	200,000		700,000
Fair values at the date of grant of awards granted (in dollars per share)							$ 32.88		$ 32.88
Grant Date Fair Value, Total							$ 120,000
Grant Date Fair Value, Total									23,020,000
Number of years used in average of performance goals for fiscal years ending February 2015 to determine if higher than fiscal 2015 specified performance goal													3
Stock options exercised (in shares)			93,005
SHARE-BASED PAYMENT EXPENSE
Share-based payment expense	1,602,000	466,000	547,000	466,000				123,000		932,000
Less income tax benefits	(265,000)	(25,000)
Share-based payment expense, net of income tax benefits	$ 1,337,000	$ 441,000
Earnings per share impact of share based payment expense:
Basic (in dollars per share)	$ 0.04	$ 0.01
Diluted (in dollars per share)	$ 0.04	$ 0.01

XML

Debt (Details) (USD $)				3 Months Ended
	May 31, 2012	Feb. 29, 2012	May 31, 2012 2010 RCA	May 31, 2012 2010 RCA Minimum	May 31, 2011 2010 RCA Minimum	May 31, 2012 2010 RCA Maximum	May 31, 2011 2010 RCA Maximum
Short-term debt
Unsecured total revolving commitment			$ 250,000,000
Revolving loans outstanding	158,000,000	171,100,000
Open letters of credit outstanding			350,000
Interest rate (as a percent)				1.61%	1.95%	4.00%	4.00%
Amount available for borrowings			$ 91,650,000

XML

Consolidated Condensed Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012	May 31, 2011
Net income	$ 27,859	$ 27,368
Auction rate security activity, before tax
Changes in fair market value		42
Settlements reclassified to income		(120)
Subtotal		(78)
Total other comprehensive income, before tax	1,731	(1,274)
Comprehensive income, before tax	29,590	26,094
Net income, tax	(4,387)	(2,763)
Auction rate security activity, tax
Changes in fair market value		(22)
Settlements reclassified to income		63
Subtotal		41
Total other comprehensive income, tax	(606)	547
Comprehensive income, tax	(4,993)	(2,216)
Net income	23,472	24,605
Auction rate security activity, net of tax
Changes in fair market value		20
Settlements reclassified to income		(57)
Subtotal		(37)
Total other comprehensive income, net of tax	1,125	(727)
Comprehensive income, net of tax	24,597	23,878
Interest rate swaps
Cash flow hedge activity, before tax
Changes in fair market value	(44)	(2,442)
Settlements reclassified to income	926	1,526
Subtotal	882	(916)
Cash flow hedge activity, tax
Changes in fair market value	15	1,111
Settlements reclassified to income	(324)	(695)
Subtotal	(309)	416
Cash flow hedge activity, net of tax
Changes in fair market value	(29)	(1,331)
Settlements reclassified to income	602	831
Subtotal	573	(500)
Foreign currency contracts
Cash flow hedge activity, before tax
Changes in fair market value	910	(487)
Ineffectiveness recorded in income	(35)	63
Settlements reclassified to income	(26)	144
Subtotal	849	(280)
Cash flow hedge activity, tax
Changes in fair market value	(318)	156
Ineffectiveness recorded in income	12	(20)
Settlements reclassified to income	9	(46)
Subtotal	(297)	90
Cash flow hedge activity, net of tax
Changes in fair market value	592	(331)
Ineffectiveness recorded in income	(23)	43
Settlements reclassified to income	(17)	98
Subtotal	$ 552	$ (190)

XML

Earnings per Share

3 Months Ended

May 31, 2012

Earnings per Share

Earnings per Share

Note 4 – Earnings per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period and diluted earnings per share using basic earnings per share plus the effect of dilutive securities.  Our securities that can have dilutive effects consist of outstanding options to purchase common stock and restricted share units.  “In-the-money” options to purchase common stock are dilutive because they have exercise prices that are less than the average market price of our common stock during the period reported.  “Out-of-the-money” options to purchase common stock are antidilutive and are excluded from the computation of earnings per share because the exercise price of the options was greater than the average market price of our common stock during the period reported.  For the periods covered in the accompanying consolidated condensed statements of income, the basic and diluted shares are as follows:

WEIGHTED AVERAGE DILUTED SECURITIES

(in thousands)

	Three Months Ended May 31,
	2012	2011
Weighted average shares outstanding, basic	31,699	30,857
Incremental shares of common stock attributable to share-based payment arrangements	141	803
Weighted average shares outstanding, diluted	31,840	31,660
Dilutive securities, as a result of in-the-money options	423	2,338
Antidilutive securities, as a result of out-of-the-money options	625	407

XML

Acquisitions (Tables) (PUR)

3 Months Ended

May 31, 2012

PUR

Acquisitions

Schedule of net assets acquired

(in thousands)
Supplier tooling advances	$	1,432
Tools, dies, molds and other production equipment	12,495
Goodwill	86,162
Trademarks	54,000
Trademark and technology licensing agreements	14,900
Patents	4,140
Customer list	18,600
Covenant not to compete	200
Total assets acquired	191,929
Less: Deferred tax liabilities recorded at acquisition	(31,929		)
Net assets acquired	$	160,000

XML

Supplemental Balance Sheet Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 31, 2012 Y	Feb. 29, 2012
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 168,328	$ 163,240
Less accumulated depreciation	(67,498)	(62,550)
Property and equipment, net	100,830	100,690
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued sales returns, discounts and allowances	27,885	29,481
Accrued warranty returns	23,313	26,665
Accrued compensation, benefits and payroll taxes	16,673	31,754
Accrued advertising	9,865	7,849
Accrued royalties	6,059	6,990
Accrued property, sales and other taxes	6,012	5,745
Accrued legal expenses and professional fees	5,482	5,364
Derivative liabilities	3,464	3,694
Other	14,698	14,090
Total accrued expenses and other current liabilities	113,451	131,632
OTHER LIABILITIES, NONCURRENT
Deferred compensation liability	4,648	4,478
Liability for uncertain tax positions	13,284	13,213
Derivative liabilities	4,207	5,022
Other liabilities	1,661	1,816
Total other liabilities, noncurrent	23,800	24,529
Land
PROPERTY AND EQUIPMENT
Property and equipment, gross	8,767	8,767
Building and improvements
PROPERTY AND EQUIPMENT
Estimated useful life, low end of range (in years)	3
Estimated useful life, high end of range (in years)	40
Property and equipment, gross	66,953	66,580
Computer, furniture and other equipment
PROPERTY AND EQUIPMENT
Estimated useful life, low end of range (in years)	3
Estimated useful life, high end of range (in years)	15
Property and equipment, gross	57,475	56,162
Tools, molds and other production equipment
PROPERTY AND EQUIPMENT
Estimated useful life, low end of range (in years)	1
Estimated useful life, high end of range (in years)	10
Property and equipment, gross	30,165	25,617
Construction in progress
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 4,968	$ 6,114

XML

Share-Based Compensation Plans

3 Months Ended

May 31, 2012

Share-Based Compensation Plans

Share-Based Compensation Plans

Note 14 – Share-Based Compensation Plans

We have options outstanding under two expired and three active share-based compensation plans.

During the fiscal quarter ended May 31, 2012, the Company granted options to purchase 301,000 shares of common stock at exercise prices ranging from $32.52 to $34.72 per share to certain of our officers, employees and new hires.  The fair value of the options were estimated using the Black-Scholes option pricing model to estimate fair values ranging from $13.16 to $14.57 for grants with terms of four and five years.  The following assumptions were used for the grants: expected lives ranging from 4.05 to 4.35 years; risk free interest rates ranging from  0.61 to 0.86  percent; zero dividend yield; and expected volatilities ranging from 50.95 to 52.48 percent.

On March 1, 2012, the Company granted 3,750 shares of restricted stock to certain board members, having fair values at the date of grant of $32.88 per share for a total value granted of $0.12 million. The restricted stock awards vested immediately and were valued at the fair value of the Company’s common stock at the date of the grant.

On March 1, 2012, under the terms of his employment agreement, our Chief Executive Officer and President was granted 700,000 restricted stock units (the “Performance RSUs”), which may be earned in tranches based on the Company’s achievement of specified performance goals for fiscal years 2013, 2014 and 2015.  Any earned Performance RSUs are subject to additional time-based vesting requirements. Up to 100,000 and 200,000 Performance RSUs may be earned based on the Company’s achievement of the specified performance goals for fiscal years 2013 and 2014, respectively.  Up to 700,000 Performance RSUs (less the number of Performance RSUs previously earned, if any) may be earned based on the Company’s achievement of either the specified performance goal for fiscal year 2015 or the three year average performance goal for fiscal years 2013 through 2015.  The Performance RSUs had a fair value at the date of grant of $32.88 per share for a grant date fair value of  $23.02 million.  Compensation expense associated with Performance RSUs is equal to the market value of our common stock on the date of the grant multiplied by the number of Performance RSUs vesting during any given period.  Expense for each tranche must be estimated until earned, subject to a probability assessment of achieving the performance criteria specified for the tranche. We are recording the expense for each tranche over the related service periods.

During the fiscal quarter ended May 31, 2012, employees exercised stock options to purchase 93,005 shares of common stock.

We recorded share-based compensation expense in SG&A for the periods covered in the accompanying consolidated condensed financial statements as follows:

SHARE-BASED PAYMENT EXPENSE

(in thousands, except per share data)

	Three Months Ended May 31,
	2012			2011
Stock options	$	547		$	466
Directors stock compensation	123			-
Performance based restricted stock awards and units	932			-
Share-based payment expense	1,602			466
Less income tax benefits	(265		)	(25		)
Share-based payment expense, net of income tax benefits	$	1,337		$	441
Earnings per share impact of share based payment expense:
Basic	$	0.04		$	0.01
Diluted	$	0.04		$	0.01